<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PubTator</source><date>2021-11-30</date><key>BioC.key</key><document><id>14510914</id><passage><infon key="type">title</infon><offset>0</offset><text>Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein.</text><annotation id="0"><infon key="identifier">D003409</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="0" length="25"/><text>Congenital hypothyroidism</text></annotation><annotation id="1"><infon key="identifier">6528</infon><infon key="type">GeneOrGeneProduct</infon><location offset="55" length="23"/><text>sodium/iodide symporter</text></annotation></passage><passage><infon key="type">abstract</infon><offset>88</offset><text>OBJECTIVE: Iodide transport defect (ITD) is a rare disorder characterised by an inability of the thyroid to maintain an iodide gradient across the basolateral membrane of thyroid follicular cells, that often results in congenital hypothyroidism. When present the defect is also found in the salivary glands and gastric mucosa and it has been shown to arise from abnormalities of the sodium/iodide symporter (NIS). PATIENT: We describe a woman with hypothyroidism identified at the 3rd month of life. The diagnosis of ITD was suspected because of nodular goitre, and little if any iodide uptake by the thyroid and salivary glands. Treatment with iodide partially corrected the hypothyroidism; however, long-term substitution therapy with L-thyroxine was started. MEASUREMENTS: Thyroid radioiodide uptake was only 1.4% and 0.3% at 1 and 24 h after the administration of recombinant human TSH. The saliva to plasma I- ratio was 1.1 indicating that the inability of the thyroid gland to concentrate I- was also present in the salivary glands. RESULTS: Analysis of the patient's NIS gene revealed a 15 nucleotide (nt) deletion of the coding sequence (nt 1314 through nt 1328) and the insertion of 15 nt duplicating the first 15 nt of the adjacent intron. The patient was homozygous for this insertion/deletion, while both consanguineous parents were heterozygous. This deletion predicts the production of a protein lacking the five terminal amino acids of exon XI (439-443) which are located in the 6th intracellular loop. COS-7 cells transfected with a vector expressing the mutant del-(439-443) NIS failed to concentrate iodide, suggesting that the mutation was the direct cause of the ITD in this patient. CONCLUSION: In conclusion we describe the first Italian case of congenital hypothyroidism due to a new deletion in the NIS gene.</text><annotation id="2"><infon key="identifier">C564766</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="99" length="23"/><text>Iodide transport defect</text></annotation><annotation id="3"><infon key="identifier">C564766</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="124" length="3"/><text>ITD</text></annotation><annotation id="4"><infon key="identifier">D050033</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="168" length="24"/><text>inability of the thyroid</text></annotation><annotation id="5"><infon key="identifier">D007454</infon><infon key="type">ChemicalEntity</infon><location offset="208" length="6"/><text>iodide</text></annotation><annotation id="6"><infon key="identifier">D003409</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="307" length="25"/><text>congenital hypothyroidism</text></annotation><annotation id="7"><infon key="identifier">6528</infon><infon key="type">GeneOrGeneProduct</infon><location offset="471" length="23"/><text>sodium/iodide symporter</text></annotation><annotation id="8"><infon key="identifier">6528</infon><infon key="type">GeneOrGeneProduct</infon><location offset="496" length="3"/><text>NIS</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="502" length="7"/><text>PATIENT</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="525" length="5"/><text>woman</text></annotation><annotation id="11"><infon key="identifier">D007037</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="536" length="14"/><text>hypothyroidism</text></annotation><annotation id="12"><infon key="identifier">C564766</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="605" length="3"/><text>ITD</text></annotation><annotation id="13"><infon key="identifier">D020518</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="634" length="14"/><text>nodular goitre</text></annotation><annotation id="14"><infon key="identifier">D007454</infon><infon key="type">ChemicalEntity</infon><location offset="668" length="6"/><text>iodide</text></annotation><annotation id="15"><infon key="identifier">D007454</infon><infon key="type">ChemicalEntity</infon><location offset="733" length="6"/><text>iodide</text></annotation><annotation id="16"><infon key="identifier">D007037</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="764" length="14"/><text>hypothyroidism</text></annotation><annotation id="17"><infon key="identifier">D013974</infon><infon key="type">ChemicalEntity</infon><location offset="825" length="11"/><text>L-thyroxine</text></annotation><annotation id="18"><infon key="identifier">D007454</infon><infon key="type">ChemicalEntity</infon><location offset="872" length="11"/><text>radioiodide</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="968" length="5"/><text>human</text></annotation><annotation id="20"><infon key="identifier">7200</infon><infon key="type">GeneOrGeneProduct</infon><location offset="974" length="3"/><text>TSH</text></annotation><annotation id="21"><infon key="identifier">D007454</infon><infon key="type">ChemicalEntity</infon><location offset="1000" length="2"/><text>I-</text></annotation><annotation id="22"><infon key="identifier">D007454</infon><infon key="type">ChemicalEntity</infon><location offset="1083" length="2"/><text>I-</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1152" length="7"/><text>patient</text></annotation><annotation id="24"><infon key="identifier">6528</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1162" length="3"/><text>NIS</text></annotation><annotation id="25"><infon key="identifier">c|DEL|1314_1328|</infon><infon key="type">SequenceVariant</infon><location offset="1201" length="57"/><text>deletion of the coding sequence (nt 1314 through nt 1328)</text></annotation><annotation id="26"><infon key="identifier">c|DUP||15</infon><infon key="type">SequenceVariant</infon><location offset="1267" length="43"/><text>insertion of 15 nt duplicating the first 15</text></annotation><annotation id="27"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1342" length="7"/><text>patient</text></annotation><annotation id="28"><infon key="identifier">p|DEL|439_443|</infon><infon key="type">SequenceVariant</infon><location offset="1498" length="58"/><text>lacking the five terminal amino acids of exon XI (439-443)</text></annotation><annotation id="29"><infon key="identifier">CVCL_0224</infon><infon key="type">CellLine</infon><location offset="1606" length="5"/><text>COS-7</text></annotation><annotation id="30"><infon key="identifier">p|DEL|439_443|</infon><infon key="type">SequenceVariant</infon><location offset="1666" length="13"/><text>del-(439-443)</text></annotation><annotation id="31"><infon key="identifier">6528</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1680" length="3"/><text>NIS</text></annotation><annotation id="32"><infon key="identifier">D007454</infon><infon key="type">ChemicalEntity</infon><location offset="1706" length="6"/><text>iodide</text></annotation><annotation id="33"><infon key="identifier">C564766</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1771" length="3"/><text>ITD</text></annotation><annotation id="34"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1783" length="7"/><text>patient</text></annotation><annotation id="35"><infon key="identifier">D003409</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1856" length="25"/><text>congenital hypothyroidism</text></annotation><annotation id="36"><infon key="identifier">6528</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1911" length="3"/><text>NIS</text></annotation></passage><relation id="R0"><infon key="entity1">c|DEL|1314_1328|</infon><infon key="entity2">D003409</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D050033</infon><infon key="entity2">D007454</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">p|DEL|439_443|</infon><infon key="entity2">C564766</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">p|DEL|439_443|</infon><infon key="entity2">D003409</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">C564766</infon><infon key="entity2">D007454</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R5"><infon key="entity1">C564766</infon><infon key="entity2">6528</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R6"><infon key="entity1">D013974</infon><infon key="entity2">D007037</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R7"><infon key="entity1">D007454</infon><infon key="entity2">p|DEL|439_443|</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">D007454</infon><infon key="entity2">6528</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R9"><infon key="entity1">D007037</infon><infon key="entity2">D007454</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R10"><infon key="entity1">D003409</infon><infon key="entity2">c|DUP||15</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">D003409</infon><infon key="entity2">6528</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>15096016</id><passage><infon key="type">title</infon><offset>0</offset><text>Pallidal stimulation: an alternative to pallidotomy?</text></passage><passage><infon key="type">abstract</infon><offset>53</offset><text>A resurgence of interest in the surgical treatment of Parkinson's disease (PD) came with the rediscovery of posteroventral pallidotomy by Laitinen in 1985. Laitinen's procedure improved most symptoms in drug-resistant PD, which engendered wide interest in the neurosurgical community. Another lesioning procedure, ventrolateral thalamotomy, has become a powerful alternative to stimulate the nucleus ventralis intermedius, producing high long-term success rates and low morbidity rates. Pallidal stimulation has not met with the same success. According to the literature pallidotomy improves the "on" symptoms of PD, such as dyskinesias, as well as the "off" symptoms, such as rigidity, bradykinesia, and on-off fluctuations. Pallidal stimulation improves bradykinesia and rigidity to a minor extent; however, its strength seems to be in improving levodopa-induced dyskinesias. Stimulation often produces an improvement in the hyper- or dyskinetic upper limbs, but increases the "freezing" phenomenon in the lower limbs at the same time. Considering the small increase in the patient's independence, the high costs of bilateral implants, and the difficulty most patients experience in handling the devices, the question arises as to whether bilateral pallidal stimulation is a real alternative to pallidotomy.</text><annotation id="0"><infon key="identifier">D010300</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="107" length="19"/><text>Parkinson's disease</text></annotation><annotation id="1"><infon key="identifier">D010300</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="128" length="2"/><text>PD</text></annotation><annotation id="2"><infon key="identifier">D010300</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="271" length="2"/><text>PD</text></annotation><annotation id="3"><infon key="identifier">D010300</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="666" length="2"/><text>PD</text></annotation><annotation id="4"><infon key="identifier">D004409</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="678" length="11"/><text>dyskinesias</text></annotation><annotation id="5"><infon key="identifier">D009127</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="730" length="8"/><text>rigidity</text></annotation><annotation id="6"><infon key="identifier">D018476</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="740" length="12"/><text>bradykinesia</text></annotation><annotation id="7"><infon key="identifier">D018476</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="809" length="12"/><text>bradykinesia</text></annotation><annotation id="8"><infon key="identifier">D009127</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="826" length="8"/><text>rigidity</text></annotation><annotation id="9"><infon key="identifier">D007980</infon><infon key="type">ChemicalEntity</infon><location offset="901" length="8"/><text>levodopa</text></annotation><annotation id="10"><infon key="identifier">D004409</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="918" length="11"/><text>dyskinesias</text></annotation><annotation id="11"><infon key="identifier">D004409,D006948</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="980" length="20"/><text>hyper- or dyskinetic</text></annotation><annotation id="12"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1129" length="7"/><text>patient</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1215" length="8"/><text>patients</text></annotation></passage><relation id="R0"><infon key="entity1">D007980</infon><infon key="entity2">D004409</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation></document><document><id>16152606</id><passage><infon key="type">title</infon><offset>0</offset><text>Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies.</text><annotation id="0"><infon key="identifier">c|DEL|657|5</infon><infon key="type">SequenceVariant</infon><location offset="30" length="7"/><text>657del5</text></annotation><annotation id="1"><infon key="identifier">4683</infon><infon key="type">GeneOrGeneProduct</infon><location offset="45" length="4"/><text>NBS1</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="91" length="8"/><text>patients</text></annotation><annotation id="3"><infon key="identifier">D008223</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="105" length="30"/><text>sporadic lymphoid malignancies</text></annotation></passage><passage><infon key="type">abstract</infon><offset>137</offset><text>Nijmegen breakage syndrome (NBS) is a human autosomal recessive disease characterized by genomic instability and enhanced cancer predisposition, in particular to lymphoma and leukemia. Recently, significantly higher frequencies of heterozygous carriers of the Slavic founder NBS1 mutation, 657del5, were found in Russian children with sporadic lymphoid malignancies, and in Polish adults with non-Hodgkin lymphoma (NHL). In addition, the substitution 643C>T (R215W) has also been found in excess among children with acute lymphoblastic leukemia (ALL). In an attempt to asses the contribution of both mutations to the development of sporadic lymphoid malignancies, we analyzed DNA samples from a large group of Polish pediatric patients. The NBS1 mutation 657del5 on one allele was found in 3 of 270 patients with ALL and 2 of 212 children and adolescents with NHL; no carrier was found among 63 patients with Hodgkin lymphoma (HL). No carriers of the variant R215W were detected in any studied group. The relative frequency of the 657del5 mutation was calculated from a total of 6,984 controls matched by place of patient residence, of whom 42 were found to be carriers (frequency = 0.006). In the analyzed population with malignancies, an increased odds ratio for the occurrence of mutation 657del5 was found in comparison with the control Polish population (OR range 1.48-1.85, 95% confidence interval 1.18-2.65). This finding indicates that the frequency of the mutation carriers was indeed increased in patients with ALL and NHL (p &lt; 0.05). Nonetheless, NBS1 gene heterozygosity is not a major risk factor for lymphoid malignancies in childhood and adolescence.</text><annotation id="4"><infon key="identifier">D049932</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="137" length="26"/><text>Nijmegen breakage syndrome</text></annotation><annotation id="5"><infon key="identifier">D049932</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="165" length="3"/><text>NBS</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="175" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">D030342</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="181" length="27"/><text>autosomal recessive disease</text></annotation><annotation id="8"><infon key="identifier">D009369</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="259" length="6"/><text>cancer</text></annotation><annotation id="9"><infon key="identifier">D008223</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="299" length="8"/><text>lymphoma</text></annotation><annotation id="10"><infon key="identifier">D007938</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="312" length="8"/><text>leukemia</text></annotation><annotation id="11"><infon key="identifier">4683</infon><infon key="type">GeneOrGeneProduct</infon><location offset="412" length="4"/><text>NBS1</text></annotation><annotation id="12"><infon key="identifier">c|DEL|657|5</infon><infon key="type">SequenceVariant</infon><location offset="427" length="7"/><text>657del5</text></annotation><annotation id="13"><infon key="identifier">D008223</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="472" length="30"/><text>sporadic lymphoid malignancies</text></annotation><annotation id="14"><infon key="identifier">D008228</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="530" length="20"/><text>non-Hodgkin lymphoma</text></annotation><annotation id="15"><infon key="identifier">D008228</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="552" length="3"/><text>NHL</text></annotation><annotation id="16"><infon key="identifier">c|SUB|C|643|T</infon><infon key="type">SequenceVariant</infon><location offset="588" length="6"/><text>643C>T</text></annotation><annotation id="17"><infon key="identifier">p|SUB|R|215|W</infon><infon key="type">SequenceVariant</infon><location offset="596" length="5"/><text>R215W</text></annotation><annotation id="18"><infon key="identifier">D054198</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="653" length="28"/><text>acute lymphoblastic leukemia</text></annotation><annotation id="19"><infon key="identifier">D054198</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="683" length="3"/><text>ALL</text></annotation><annotation id="20"><infon key="identifier">D008223</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="769" length="30"/><text>sporadic lymphoid malignancies</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="864" length="8"/><text>patients</text></annotation><annotation id="22"><infon key="identifier">4683</infon><infon key="type">GeneOrGeneProduct</infon><location offset="878" length="4"/><text>NBS1</text></annotation><annotation id="23"><infon key="identifier">c|DEL|657|5</infon><infon key="type">SequenceVariant</infon><location offset="892" length="7"/><text>657del5</text></annotation><annotation id="24"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="936" length="8"/><text>patients</text></annotation><annotation id="25"><infon key="identifier">D054198</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="950" length="3"/><text>ALL</text></annotation><annotation id="26"><infon key="identifier">D008228</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="997" length="3"/><text>NHL</text></annotation><annotation id="27"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1032" length="8"/><text>patients</text></annotation><annotation id="28"><infon key="identifier">D006689</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1046" length="16"/><text>Hodgkin lymphoma</text></annotation><annotation id="29"><infon key="identifier">D006689</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1064" length="2"/><text>HL</text></annotation><annotation id="30"><infon key="identifier">p|SUB|R|215|W</infon><infon key="type">SequenceVariant</infon><location offset="1096" length="5"/><text>R215W</text></annotation><annotation id="31"><infon key="identifier">c|DEL|657|5</infon><infon key="type">SequenceVariant</infon><location offset="1168" length="7"/><text>657del5</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1251" length="7"/><text>patient</text></annotation><annotation id="33"><infon key="identifier">D009369</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1360" length="12"/><text>malignancies</text></annotation><annotation id="34"><infon key="identifier">c|DEL|657|5</infon><infon key="type">SequenceVariant</infon><location offset="1429" length="7"/><text>657del5</text></annotation><annotation id="35"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1644" length="8"/><text>patients</text></annotation><annotation id="36"><infon key="identifier">D054198</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1658" length="3"/><text>ALL</text></annotation><annotation id="37"><infon key="identifier">D008228</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1666" length="3"/><text>NHL</text></annotation><annotation id="38"><infon key="identifier">4683</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1695" length="4"/><text>NBS1</text></annotation><annotation id="39"><infon key="identifier">D008223</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1751" length="21"/><text>lymphoid malignancies</text></annotation></passage><relation id="R0"><infon key="entity1">D009369</infon><infon key="entity2">c|DEL|657|5</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D054198</infon><infon key="entity2">p|SUB|R|215|W</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">D054198</infon><infon key="entity2">c|SUB|C|643|T</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">D054198</infon><infon key="entity2">c|DEL|657|5</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">4683</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R5"><infon key="entity1">4683</infon><infon key="entity2">D008228</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R6"><infon key="entity1">4683</infon><infon key="entity2">D054198</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R7"><infon key="entity1">4683</infon><infon key="entity2">D008223</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R8"><infon key="entity1">c|DEL|657|5</infon><infon key="entity2">D008228</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R9"><infon key="entity1">D008223</infon><infon key="entity2">c|DEL|657|5</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>16277682</id><passage><infon key="type">title</infon><offset>0</offset><text>Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family.</text><annotation id="0"><infon key="identifier">rs771966860</infon><infon key="type">SequenceVariant</infon><location offset="17" length="5"/><text>M404V</text></annotation><annotation id="1"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="39" length="3"/><text>p62</text></annotation><annotation id="2"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="43" length="14"/><text>sequestosome 1</text></annotation><annotation id="3"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="59" length="3"/><text>p62</text></annotation><annotation id="4"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="63" length="6"/><text>SQSTM1</text></annotation><annotation id="5"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="93" length="23"/><text>Paget's disease of bone</text></annotation></passage><passage><infon key="type">abstract</infon><offset>139</offset><text>Mutations of the p62/Sequestosome 1 gene (p62/SQSTM1) account for both sporadic and familial forms of Paget's disease of bone (PDB). We originally described a methionine-->valine substitution at codon 404 (M404V) of exon 8, in the ubiquitin protein-binding domain of p62/SQSTM1 gene in an Italian PDB patient. The collection of data from the patient's pedigree provided evidence for a familial form of PDB. Extension of the genetic analysis to other relatives in this family demonstrated segregation of the M404V mutation with the polyostotic PDB phenotype and provided the identification of six asymptomatic gene carriers. DNA for mutational analysis of the exon 8 coding sequence was obtained from 22 subjects, 4 PDB patients and 18 clinically unaffected members. Of the five clinically ascertained affected members of the family, four possessed the M404V mutation and exhibited the polyostotic form of PDB, except one patient with a single X-ray-assessed skeletal localization and one with a polyostotic disease who had died several years before the DNA analysis. By both reconstitution and mutational analysis of the pedigree, six unaffected subjects were shown to bear the M404V mutation, representing potential asymptomatic gene carriers whose circulating levels of alkaline phosphatase were recently assessed as still within the normal range. Taken together, these results support a genotype-phenotype correlation between the M404V mutation in the p62/SQSTM1 gene and a polyostotic form of PDB in this family. The high penetrance of the PDB trait in this family together with the study of the asymptomatic gene carriers will allow us to confirm the proposed genotype-phenotype correlation and to evaluate the potential use of mutational analysis of the p62/SQSTM1 gene in the early detection of relatives at risk for PDB.</text><annotation id="6"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="156" length="3"/><text>p62</text></annotation><annotation id="7"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="160" length="14"/><text>Sequestosome 1</text></annotation><annotation id="8"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="181" length="3"/><text>p62</text></annotation><annotation id="9"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="185" length="6"/><text>SQSTM1</text></annotation><annotation id="10"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="241" length="23"/><text>Paget's disease of bone</text></annotation><annotation id="11"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="266" length="3"/><text>PDB</text></annotation><annotation id="12"><infon key="identifier">rs771966860</infon><infon key="type">SequenceVariant</infon><location offset="298" length="45"/><text>methionine-->valine substitution at codon 404</text></annotation><annotation id="13"><infon key="identifier">rs771966860</infon><infon key="type">SequenceVariant</infon><location offset="345" length="5"/><text>M404V</text></annotation><annotation id="14"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="406" length="3"/><text>p62</text></annotation><annotation id="15"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="410" length="6"/><text>SQSTM1</text></annotation><annotation id="16"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="436" length="3"/><text>PDB</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="440" length="7"/><text>patient</text></annotation><annotation id="18"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="481" length="7"/><text>patient</text></annotation><annotation id="19"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="541" length="3"/><text>PDB</text></annotation><annotation id="20"><infon key="identifier">rs771966860</infon><infon key="type">SequenceVariant</infon><location offset="646" length="5"/><text>M404V</text></annotation><annotation id="21"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="682" length="3"/><text>PDB</text></annotation><annotation id="22"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="854" length="3"/><text>PDB</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="858" length="8"/><text>patients</text></annotation><annotation id="24"><infon key="identifier">rs771966860</infon><infon key="type">SequenceVariant</infon><location offset="991" length="5"/><text>M404V</text></annotation><annotation id="25"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1044" length="3"/><text>PDB</text></annotation><annotation id="26"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1060" length="7"/><text>patient</text></annotation><annotation id="27"><infon key="identifier">D005357</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1134" length="19"/><text>polyostotic disease</text></annotation><annotation id="28"><infon key="identifier">rs771966860</infon><infon key="type">SequenceVariant</infon><location offset="1317" length="5"/><text>M404V</text></annotation><annotation id="29"><infon key="identifier">D000469</infon><infon key="type">ChemicalEntity</infon><location offset="1411" length="20"/><text>alkaline phosphatase</text></annotation><annotation id="30"><infon key="identifier">rs771966860</infon><infon key="type">SequenceVariant</infon><location offset="1572" length="5"/><text>M404V</text></annotation><annotation id="31"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1594" length="3"/><text>p62</text></annotation><annotation id="32"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1598" length="6"/><text>SQSTM1</text></annotation><annotation id="33"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1636" length="3"/><text>PDB</text></annotation><annotation id="34"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1683" length="3"/><text>PDB</text></annotation><annotation id="35"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1899" length="3"/><text>p62</text></annotation><annotation id="36"><infon key="identifier">8878</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1903" length="6"/><text>SQSTM1</text></annotation><annotation id="37"><infon key="identifier">C538098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1963" length="3"/><text>PDB</text></annotation></passage><relation id="R0"><infon key="entity1">8878</infon><infon key="entity2">D005357</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">8878</infon><infon key="entity2">C538098</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">rs771966860</infon><infon key="entity2">D005357</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">C538098</infon><infon key="entity2">rs771966860</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>1671881</id><passage><infon key="type">title</infon><offset>0</offset><text>Two distinct mutations at a single BamHI site in phenylketonuria.</text><annotation id="0"><infon key="identifier">D010661</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="49" length="15"/><text>phenylketonuria</text></annotation></passage><passage><infon key="type">abstract</infon><offset>66</offset><text>Classical phenylketonuria is an autosomal recessive disease caused by a deficiency of hepatic phenylalanine hydroxylase (PAH). The abolition of an invariant BamHI site located in the coding sequence of the PAH gene (exon 7) led to the recognition of two new point mutations at codon 272 and 273 (272gly----stop and 273ser----phe, respectively). Both mutations were detected in north eastern France or Belgium and occurred on the background of RFLP haplotype 7 alleles. The present study supports the view that the clinical heterogeneity in PKU is accounted for by the large variety of mutant genotypes associated with PAH deficiencies.. </text><annotation id="1"><infon key="identifier">D010661</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="66" length="25"/><text>Classical phenylketonuria</text></annotation><annotation id="2"><infon key="identifier">D030342</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="98" length="27"/><text>autosomal recessive disease</text></annotation><annotation id="3"><infon key="identifier">OMIM:261600</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="138" length="47"/><text>deficiency of hepatic phenylalanine hydroxylase</text></annotation><annotation id="4"><infon key="identifier">5053</infon><infon key="type">GeneOrGeneProduct</infon><location offset="187" length="3"/><text>PAH</text></annotation><annotation id="5"><infon key="identifier">5053</infon><infon key="type">GeneOrGeneProduct</infon><location offset="272" length="3"/><text>PAH</text></annotation><annotation id="6"><infon key="identifier">rs62514952</infon><infon key="type">SequenceVariant</infon><location offset="362" length="14"/><text>272gly----stop</text></annotation><annotation id="7"><infon key="identifier">rs62514953</infon><infon key="type">SequenceVariant</infon><location offset="381" length="13"/><text>273ser----phe</text></annotation><annotation id="8"><infon key="identifier">D010661</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="606" length="3"/><text>PKU</text></annotation><annotation id="9"><infon key="identifier">OMIM:261600</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="684" length="16"/><text>PAH deficiencies</text></annotation></passage><relation id="R0"><infon key="entity1">D010661</infon><infon key="entity2">rs62514952</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D010661</infon><infon key="entity2">rs62514953</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">5053</infon><infon key="entity2">D010661</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">5053</infon><infon key="entity2">OMIM:261600</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R4"><infon key="entity1">rs62514952</infon><infon key="entity2">OMIM:261600</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">rs62514953</infon><infon key="entity2">OMIM:261600</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>16867246</id><passage><infon key="type">title</infon><offset>0</offset><text>Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients.</text><annotation id="0"><infon key="identifier">1813</infon><infon key="type">GeneOrGeneProduct</infon><location offset="15" length="4"/><text>DRD2</text></annotation><annotation id="1"><infon key="identifier">D002746</infon><infon key="type">ChemicalEntity</infon><location offset="38" length="14"/><text>chlorpromazine</text></annotation><annotation id="2"><infon key="identifier">D001480</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="61" length="23"/><text>extrapyramidal syndrome</text></annotation><annotation id="3"><infon key="identifier">D012559</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="96" length="13"/><text>schizophrenic</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="110" length="8"/><text>patients</text></annotation></passage><passage><infon key="type">abstract</infon><offset>120</offset><text>AIM: Extrapyramidal syndrome (EPS) is most commonly affected by typical antipsychotic drugs that have a high affinity with the D2 receptor. Recently, many research groups have reported on the positive relationship between the genetic variations in the DRD2 gene and the therapeutic response in schizophrenia patients as a result of the role of variations in the receptor in modulating receptor expression. In this study, we evaluate the role DRD2 plays in chlorpromazine-induced EPS in schizophrenic patients. METHODS: We identified seven SNP(single nucleotide polymorphism) (-141Cins>del, TaqIB, TaqID, Ser311Cys, rs6275, rs6277 and TaqIA) in the DRD2 gene in 146 schizophrenic inpatients (59 with EPS and 87 without EPS according to the Simpson-Angus Scale) treated with chlorpromazine after 8 weeks. The alleles of all loci were determined by PCR (polymerase chain reaction). RESULTS: Polymorphisms TaqID, Ser311Cys and rs6277 were not polymorphic in the population recruited in the present study. No statistical significance was found in the allele distribution of -141Cins>del, TaqIB, rs6275 and TaqIA or in the estimated haplotypes (constituted by TaqIB, rs6275 and TaqIA) in linkage disequilibrium between the two groups. CONCLUSION: Our results did not lend strong support to the view that the genetic variation of the DRD2 gene plays a major role in the individually variable adverse effect induced by chlorpromazine, at least in Chinese patients with schizophrenia. Our results confirmed a previous study on the relationship between DRD2 and EPS in Caucasians.</text><annotation id="5"><infon key="identifier">D001480</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="125" length="23"/><text>Extrapyramidal syndrome</text></annotation><annotation id="6"><infon key="identifier">D001480</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="150" length="3"/><text>EPS</text></annotation><annotation id="7"><infon key="identifier">D014150</infon><infon key="type">ChemicalEntity</infon><location offset="192" length="19"/><text>antipsychotic drugs</text></annotation><annotation id="8"><infon key="identifier">1813</infon><infon key="type">GeneOrGeneProduct</infon><location offset="247" length="11"/><text>D2 receptor</text></annotation><annotation id="9"><infon key="identifier">1813</infon><infon key="type">GeneOrGeneProduct</infon><location offset="372" length="4"/><text>DRD2</text></annotation><annotation id="10"><infon key="identifier">D012559</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="414" length="13"/><text>schizophrenia</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="428" length="8"/><text>patients</text></annotation><annotation id="12"><infon key="identifier">1813</infon><infon key="type">GeneOrGeneProduct</infon><location offset="562" length="4"/><text>DRD2</text></annotation><annotation id="13"><infon key="identifier">D002746</infon><infon key="type">ChemicalEntity</infon><location offset="576" length="14"/><text>chlorpromazine</text></annotation><annotation id="14"><infon key="identifier">D001480</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="599" length="3"/><text>EPS</text></annotation><annotation id="15"><infon key="identifier">D012559</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="606" length="13"/><text>schizophrenic</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="620" length="8"/><text>patients</text></annotation><annotation id="17"><infon key="identifier">c|INDEL|0141|C</infon><infon key="type">SequenceVariant</infon><location offset="696" length="12"/><text>-141Cins>del</text></annotation><annotation id="18"><infon key="identifier">c|SUB|S|311|C</infon><infon key="type">SequenceVariant</infon><location offset="724" length="9"/><text>Ser311Cys</text></annotation><annotation id="19"><infon key="identifier">rs6275</infon><infon key="type">SequenceVariant</infon><location offset="735" length="6"/><text>rs6275</text></annotation><annotation id="20"><infon key="identifier">rs6277</infon><infon key="type">SequenceVariant</infon><location offset="743" length="6"/><text>rs6277</text></annotation><annotation id="21"><infon key="identifier">1813</infon><infon key="type">GeneOrGeneProduct</infon><location offset="768" length="4"/><text>DRD2</text></annotation><annotation id="22"><infon key="identifier">D012559</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="785" length="13"/><text>schizophrenic</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="799" length="10"/><text>inpatients</text></annotation><annotation id="24"><infon key="identifier">D001480</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="819" length="3"/><text>EPS</text></annotation><annotation id="25"><infon key="identifier">D001480</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="838" length="3"/><text>EPS</text></annotation><annotation id="26"><infon key="identifier">D002746</infon><infon key="type">ChemicalEntity</infon><location offset="893" length="14"/><text>chlorpromazine</text></annotation><annotation id="27"><infon key="identifier">c|SUB|S|311|C</infon><infon key="type">SequenceVariant</infon><location offset="1029" length="9"/><text>Ser311Cys</text></annotation><annotation id="28"><infon key="identifier">rs6277</infon><infon key="type">SequenceVariant</infon><location offset="1043" length="6"/><text>rs6277</text></annotation><annotation id="29"><infon key="identifier">c|INDEL|0141|C</infon><infon key="type">SequenceVariant</infon><location offset="1189" length="12"/><text>-141Cins>del</text></annotation><annotation id="30"><infon key="identifier">rs6275</infon><infon key="type">SequenceVariant</infon><location offset="1210" length="6"/><text>rs6275</text></annotation><annotation id="31"><infon key="identifier">rs6275</infon><infon key="type">SequenceVariant</infon><location offset="1281" length="6"/><text>rs6275</text></annotation><annotation id="32"><infon key="identifier">1813</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1447" length="4"/><text>DRD2</text></annotation><annotation id="33"><infon key="identifier">D002746</infon><infon key="type">ChemicalEntity</infon><location offset="1531" length="14"/><text>chlorpromazine</text></annotation><annotation id="34"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1567" length="8"/><text>patients</text></annotation><annotation id="35"><infon key="identifier">D012559</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1581" length="13"/><text>schizophrenia</text></annotation><annotation id="36"><infon key="identifier">1813</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1663" length="4"/><text>DRD2</text></annotation><annotation id="37"><infon key="identifier">D001480</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1672" length="3"/><text>EPS</text></annotation></passage><relation id="R0"><infon key="entity1">1813</infon><infon key="entity2">D012559</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D014150</infon><infon key="entity2">1813</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">D012559</infon><infon key="entity2">D002746</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">D001480</infon><infon key="entity2">1813</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R4"><infon key="entity1">D001480</infon><infon key="entity2">D014150</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R5"><infon key="entity1">D002746</infon><infon key="entity2">D001480</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation></document><document><id>17549393</id><passage><infon key="type">title</infon><offset>0</offset><text>A novel IRF6 nonsense mutation (Y67X) in a German family with Van der Woude syndrome.</text><annotation id="0"><infon key="identifier">3664</infon><infon key="type">GeneOrGeneProduct</infon><location offset="8" length="4"/><text>IRF6</text></annotation><annotation id="1"><infon key="identifier">p|SUB|Y|67|X</infon><infon key="type">SequenceVariant</infon><location offset="32" length="4"/><text>Y67X</text></annotation><annotation id="2"><infon key="identifier">C536528</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="62" length="22"/><text>Van der Woude syndrome</text></annotation></passage><passage><infon key="type">abstract</infon><offset>86</offset><text>Van der Woude syndrome (VWS) is the most common type of syndromic orofacial cleft, which accounts for approximately 2% of all cleft lip and palate cases. It is characterised by variable association of lower lip pits, cleft lip and cleft palate, and hypodontia. VWS arises as the result of mutations in the gene encoding interferon regulatory factor 6 (IRF6). The disorder is transmitted in an autosomal dominant manner, with high penetrance and variable expressivity. Very recently, mutations of the IRF6 gene in exons 2-9 have been found in VWS patients, suggesting that this gene plays an important role in orofacial development. We report a novel mutation of the IRF6 gene in a German family. Five out of the 12 persons affected were able to be investigated. The mutation produced a stop codon within exon 4 of the IRF6 gene. All 5 patients were heterozygous for a base substitution c.201C>A changing the tyrosine codon at amino acid position 67 into a stop codon (p.Y67X) in exon 4. The premature stop codon was responsible for a truncated protein lacking parts of the DNA- binding domain and the complete Smad-interferon regulatory factor-binding domain probably essential for interactions with the Smad transcription factors.</text><annotation id="3"><infon key="identifier">C536528</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="86" length="22"/><text>Van der Woude syndrome</text></annotation><annotation id="4"><infon key="identifier">C536528</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="110" length="3"/><text>VWS</text></annotation><annotation id="5"><infon key="identifier">D002972</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="142" length="25"/><text>syndromic orofacial cleft</text></annotation><annotation id="6"><infon key="identifier">D002971,D002972</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="212" length="20"/><text>cleft lip and palate</text></annotation><annotation id="7"><infon key="identifier">C536528</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="293" length="8"/><text>lip pits</text></annotation><annotation id="8"><infon key="identifier">D002971</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="303" length="9"/><text>cleft lip</text></annotation><annotation id="9"><infon key="identifier">D002972</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="317" length="12"/><text>cleft palate</text></annotation><annotation id="10"><infon key="identifier">D000848</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="335" length="10"/><text>hypodontia</text></annotation><annotation id="11"><infon key="identifier">C536528</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="347" length="3"/><text>VWS</text></annotation><annotation id="12"><infon key="identifier">3664</infon><infon key="type">GeneOrGeneProduct</infon><location offset="406" length="30"/><text>interferon regulatory factor 6</text></annotation><annotation id="13"><infon key="identifier">3664</infon><infon key="type">GeneOrGeneProduct</infon><location offset="438" length="4"/><text>IRF6</text></annotation><annotation id="14"><infon key="identifier">3664</infon><infon key="type">GeneOrGeneProduct</infon><location offset="586" length="4"/><text>IRF6</text></annotation><annotation id="15"><infon key="identifier">C536528</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="628" length="3"/><text>VWS</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="632" length="8"/><text>patients</text></annotation><annotation id="17"><infon key="identifier">3664</infon><infon key="type">GeneOrGeneProduct</infon><location offset="752" length="4"/><text>IRF6</text></annotation><annotation id="18"><infon key="identifier">3664</infon><infon key="type">GeneOrGeneProduct</infon><location offset="904" length="4"/><text>IRF6</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="921" length="8"/><text>patients</text></annotation><annotation id="20"><infon key="identifier">c|SUB|C|201|A</infon><infon key="type">SequenceVariant</infon><location offset="972" length="8"/><text>c.201C>A</text></annotation><annotation id="21"><infon key="identifier">p|SUB|Y|67|X</infon><infon key="type">SequenceVariant</infon><location offset="994" length="52"/><text>tyrosine codon at amino acid position 67 into a stop</text></annotation><annotation id="22"><infon key="identifier">p|SUB|Y|67|X</infon><infon key="type">SequenceVariant</infon><location offset="1054" length="6"/><text>p.Y67X</text></annotation><annotation id="23"><infon key="identifier">4086</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1196" length="4"/><text>Smad</text></annotation><annotation id="24"><infon key="identifier">3664</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1201" length="28"/><text>interferon regulatory factor</text></annotation><annotation id="25"><infon key="identifier">4086</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1290" length="4"/><text>Smad</text></annotation></passage><relation id="R0"><infon key="entity1">3664</infon><infon key="entity2">4086</infon><infon key="type">Bind</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">3664</infon><infon key="entity2">C536528</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">C536528</infon><infon key="entity2">c|SUB|C|201|A</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">p|SUB|Y|67|X</infon><infon key="entity2">C536528</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>17962394</id><passage><infon key="type">title</infon><offset>0</offset><text>Skewed X inactivation in an X linked nystagmus family resulted from a novel, p.R229G, missense mutation in the FRMD7 gene.</text><annotation id="0"><infon key="identifier">C580539</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="28" length="18"/><text>X linked nystagmus</text></annotation><annotation id="1"><infon key="identifier">rs137852212</infon><infon key="type">SequenceVariant</infon><location offset="77" length="7"/><text>p.R229G</text></annotation><annotation id="2"><infon key="identifier">90167</infon><infon key="type">GeneOrGeneProduct</infon><location offset="111" length="5"/><text>FRMD7</text></annotation></passage><passage><infon key="type">abstract</infon><offset>123</offset><text>AIMS: This study aimed to identify the underlying genetic defect of a large Turkish X linked nystagmus (NYS) family. METHODS: Both Xp11 and Xq26 loci were tested by linkage analysis. The 12 exons and intron-exon junctions of the FRMD7 gene were screened by direct sequencing. X chromosome inactivation analysis was performed by enzymatic predigestion of DNA with a methylation-sensitive enzyme, followed by PCR of the polymorphic CAG repeat of the androgen receptor gene. RESULTS: The family contained 162 individuals, among whom 28 had NYS. Linkage analysis confirmed the Xq26 locus. A novel missense c.686C>G mutation, which causes the substitution of a conserved arginine at amino acid position 229 by glycine (p.R229G) in exon 8 of the FRMD7 gene, was observed. This change was not documented in 120 control individuals. The clinical findings in a female who was homozygous for the mutation were not different from those of affected heterozygous females. Skewed X inactivation was remarkable in the affected females of the family. CONCLUSIONS: A novel p.R229G mutation in the FRMD7 gene causes the NYS phenotype, and skewed X inactivation influences the manifestation of the disease in X linked NYS females.</text><annotation id="3"><infon key="identifier">D030342</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="173" length="14"/><text>genetic defect</text></annotation><annotation id="4"><infon key="identifier">C580539</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="207" length="18"/><text>X linked nystagmus</text></annotation><annotation id="5"><infon key="identifier">C580539</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="227" length="3"/><text>NYS</text></annotation><annotation id="6"><infon key="identifier">90167</infon><infon key="type">GeneOrGeneProduct</infon><location offset="352" length="5"/><text>FRMD7</text></annotation><annotation id="7"><infon key="identifier">c|DUP||CAG|</infon><infon key="type">SequenceVariant</infon><location offset="553" length="10"/><text>CAG repeat</text></annotation><annotation id="8"><infon key="identifier">367</infon><infon key="type">GeneOrGeneProduct</infon><location offset="571" length="17"/><text>androgen receptor</text></annotation><annotation id="9"><infon key="identifier">C580539</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="660" length="3"/><text>NYS</text></annotation><annotation id="10"><infon key="identifier">rs137852212</infon><infon key="type">SequenceVariant</infon><location offset="725" length="8"/><text>c.686C>G</text></annotation><annotation id="11"><infon key="identifier">rs137852212</infon><infon key="type">SequenceVariant</infon><location offset="789" length="46"/><text>arginine at amino acid position 229 by glycine</text></annotation><annotation id="12"><infon key="identifier">rs137852212</infon><infon key="type">SequenceVariant</infon><location offset="837" length="7"/><text>p.R229G</text></annotation><annotation id="13"><infon key="identifier">90167</infon><infon key="type">GeneOrGeneProduct</infon><location offset="863" length="5"/><text>FRMD7</text></annotation><annotation id="14"><infon key="identifier">rs137852212</infon><infon key="type">SequenceVariant</infon><location offset="1179" length="7"/><text>p.R229G</text></annotation><annotation id="15"><infon key="identifier">90167</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1203" length="5"/><text>FRMD7</text></annotation><annotation id="16"><infon key="identifier">C580539</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1225" length="3"/><text>NYS</text></annotation><annotation id="17"><infon key="identifier">C580539</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1313" length="12"/><text>X linked NYS</text></annotation></passage><relation id="R0"><infon key="entity1">C580539</infon><infon key="entity2">90167</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">C580539</infon><infon key="entity2">rs137852212</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>18046082</id><passage><infon key="type">title</infon><offset>0</offset><text>Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.</text><annotation id="0"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="18" length="16"/><text>apolipoprotein E</text></annotation><annotation id="1"><infon key="identifier">p|SUB|R|150|P</infon><infon key="type">SequenceVariant</infon><location offset="46" length="20"/><text>arginine 150 proline</text></annotation><annotation id="2"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="99" length="26"/><text>lipoprotein glomerulopathy</text></annotation></passage><passage><infon key="type">abstract</infon><offset>127</offset><text>BACKGROUND/AIMS: Lipoprotein glomerulopathy (LPG) is a rare disease characterized by thrombus-like substances in markedly dilated glomerular capillaries and elevated plasma levels of apolipoprotein E (apoE). Previous studies have shown that genetic disorders of apoE may contribute to the pathogenesis of LPG, but LPG may not be caused by apoE gene mutations in Chinese patients. This study investigated the association of a new variant of apoE with LPG in a Chinese family. METHODS: The apoE gene in a family with 4 LPG patients was sequenced. The polymerase chain reaction product of coding region of apoE exon 4 was cloned into pMD 18-T vector and then sequenced. RESULTS: A novel point mutation in exon 4 of the apoE gene was identified in all 4 LPG patients and 1 asymptomatic family member. Sequence analysis confirmed a nucleotide G to C point mutation in exon 4 (base 308) of the apoE gene in all patients and the asymptomatic family member. This missense mutation denotes amino acid substitution of the proline residue for arginine residue at position 150 of apoE. Those patients were all heterozygotes with apoE Guangzhou. One of 2 grandsons was a heterozygous carrier of apoE Guangzhou, although he did not have proteinuria. CONCLUSION: The results of this study suggest that apoE (arginine 150 proline) is a novel apoE variant that etiologically related to LPG. This variant (apoE Guangzhou) may cause a marked molecular conformational change of the apoE and thus impair its binding ability to lipids.</text><annotation id="3"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="144" length="26"/><text>Lipoprotein glomerulopathy</text></annotation><annotation id="4"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="172" length="3"/><text>LPG</text></annotation><annotation id="5"><infon key="identifier">D013927</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="212" length="8"/><text>thrombus</text></annotation><annotation id="6"><infon key="identifier">D007674</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="249" length="30"/><text>dilated glomerular capillaries</text></annotation><annotation id="7"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="310" length="16"/><text>apolipoprotein E</text></annotation><annotation id="8"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="328" length="4"/><text>apoE</text></annotation><annotation id="9"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="389" length="4"/><text>apoE</text></annotation><annotation id="10"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="432" length="3"/><text>LPG</text></annotation><annotation id="11"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="441" length="3"/><text>LPG</text></annotation><annotation id="12"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="466" length="4"/><text>apoE</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="497" length="8"/><text>patients</text></annotation><annotation id="14"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="567" length="4"/><text>apoE</text></annotation><annotation id="15"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="577" length="3"/><text>LPG</text></annotation><annotation id="16"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="615" length="4"/><text>apoE</text></annotation><annotation id="17"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="644" length="3"/><text>LPG</text></annotation><annotation id="18"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="648" length="8"/><text>patients</text></annotation><annotation id="19"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="730" length="4"/><text>apoE</text></annotation><annotation id="20"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="843" length="4"/><text>apoE</text></annotation><annotation id="21"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="877" length="3"/><text>LPG</text></annotation><annotation id="22"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="881" length="8"/><text>patients</text></annotation><annotation id="23"><infon key="identifier">c|SUB|G|308|C</infon><infon key="type">SequenceVariant</infon><location offset="965" length="42"/><text>G to C point mutation in exon 4 (base 308)</text></annotation><annotation id="24"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1015" length="4"/><text>apoE</text></annotation><annotation id="25"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1032" length="8"/><text>patients</text></annotation><annotation id="26"><infon key="identifier">p|SUB|R|150|P</infon><infon key="type">SequenceVariant</infon><location offset="1139" length="52"/><text>proline residue for arginine residue at position 150</text></annotation><annotation id="27"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1195" length="4"/><text>apoE</text></annotation><annotation id="28"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1207" length="8"/><text>patients</text></annotation><annotation id="29"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1244" length="4"/><text>apoE</text></annotation><annotation id="30"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1309" length="4"/><text>apoE</text></annotation><annotation id="31"><infon key="identifier">D011507</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1350" length="11"/><text>proteinuria</text></annotation><annotation id="32"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1414" length="4"/><text>apoE</text></annotation><annotation id="33"><infon key="identifier">p|SUB|R|150|P</infon><infon key="type">SequenceVariant</infon><location offset="1420" length="20"/><text>arginine 150 proline</text></annotation><annotation id="34"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1453" length="4"/><text>apoE</text></annotation><annotation id="35"><infon key="identifier">C567089</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1496" length="3"/><text>LPG</text></annotation><annotation id="36"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1515" length="4"/><text>apoE</text></annotation><annotation id="37"><infon key="identifier">348</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1589" length="4"/><text>apoE</text></annotation><annotation id="38"><infon key="identifier">D008055</infon><infon key="type">ChemicalEntity</infon><location offset="1633" length="6"/><text>lipids</text></annotation></passage><relation id="R0"><infon key="entity1">c|SUB|G|308|C</infon><infon key="entity2">D008055</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">348</infon><infon key="entity2">D008055</infon><infon key="type">Bind</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">348</infon><infon key="entity2">C567089</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">p|SUB|R|150|P</infon><infon key="entity2">D008055</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">p|SUB|R|150|P</infon><infon key="entity2">C567089</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>21054465</id><passage><infon key="type">title</infon><offset>0</offset><text>Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography.</text><annotation id="0"><infon key="identifier">1558</infon><infon key="type">GeneOrGeneProduct</infon><location offset="23" length="6"/><text>CYP2C8</text></annotation><annotation id="1"><infon key="identifier">D006973</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="33" length="12"/><text>hypertensive</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="46" length="8"/><text>patients</text></annotation></passage><passage><infon key="type">abstract</infon><offset>112</offset><text>WHAT IS KNOWN AND OBJECTIVE: CYP2C8 is involved in the cytochrome P450 (CYP) epoxygenase pathway. Arachidonic acid metabolites such as epoxyeicosatrienenoic acids and hydroxyeicosatetrenoic acids, produced may have a role in hypertension. We aimed to develop a medium through-put method for screening samples of known and new mutations of CYP2C8 using denaturing high performance liquid chromatography (DHPLC). METHODS: DNA samples from 200 subjects (hypertensive patients and healthy controls) were screened for SNPs in CYP2C8 using DHPLC. Genotypes and allelic frequencies of CYP2C8 between the healthy controls and patients with hypertension were compared. RESULTS AND DISCUSSIONS: Six variants were detected and two were new; T deletion at 5063 and substitution of C to T at 33468 in exon 8. Differences in variant frequencies were detected between the controls and hypertensive patients. The controls have significantly higher prevalence of C35322C compared to the patients. The functional significance of the SNP at 35322 requires further study. Having homozygous C35322C could be a protective factor for hypertension. WHAT IS NEW AND CONCLUSION: Denaturing high performance liquid chromatography is useful for population screening to identify new and existing SNPs. A higher frequency of the C35322T SNP was observed among hypertensive patients than control subjects. This potentially important observation requires confirmation and the clinical significance assessed.</text><annotation id="3"><infon key="identifier">1558</infon><infon key="type">GeneOrGeneProduct</infon><location offset="141" length="6"/><text>CYP2C8</text></annotation><annotation id="4"><infon key="identifier">1558</infon><infon key="type">GeneOrGeneProduct</infon><location offset="167" length="33"/><text>cytochrome P450 (CYP) epoxygenase</text></annotation><annotation id="5"><infon key="identifier">D016718</infon><infon key="type">ChemicalEntity</infon><location offset="210" length="16"/><text>Arachidonic acid</text></annotation><annotation id="6"><infon key="identifier">-</infon><infon key="type">ChemicalEntity</infon><location offset="247" length="27"/><text>epoxyeicosatrienenoic acids</text></annotation><annotation id="7"><infon key="identifier">-</infon><infon key="type">ChemicalEntity</infon><location offset="279" length="28"/><text>hydroxyeicosatetrenoic acids</text></annotation><annotation id="8"><infon key="identifier">D006973</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="337" length="12"/><text>hypertension</text></annotation><annotation id="9"><infon key="identifier">1558</infon><infon key="type">GeneOrGeneProduct</infon><location offset="451" length="6"/><text>CYP2C8</text></annotation><annotation id="10"><infon key="identifier">D006973</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="563" length="12"/><text>hypertensive</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="576" length="8"/><text>patients</text></annotation><annotation id="12"><infon key="identifier">1558</infon><infon key="type">GeneOrGeneProduct</infon><location offset="633" length="6"/><text>CYP2C8</text></annotation><annotation id="13"><infon key="identifier">1558</infon><infon key="type">GeneOrGeneProduct</infon><location offset="690" length="6"/><text>CYP2C8</text></annotation><annotation id="14"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="730" length="8"/><text>patients</text></annotation><annotation id="15"><infon key="identifier">D006973</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="744" length="12"/><text>hypertension</text></annotation><annotation id="16"><infon key="identifier">c|DEL|5063|T</infon><infon key="type">SequenceVariant</infon><location offset="842" length="18"/><text>T deletion at 5063</text></annotation><annotation id="17"><infon key="identifier">c|SUB|C|33468|T</infon><infon key="type">SequenceVariant</infon><location offset="881" length="15"/><text>C to T at 33468</text></annotation><annotation id="18"><infon key="identifier">D006973</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="982" length="12"/><text>hypertensive</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="995" length="8"/><text>patients</text></annotation><annotation id="20"><infon key="identifier">c|SUB|C|35322|C</infon><infon key="type">SequenceVariant</infon><location offset="1058" length="7"/><text>C35322C</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1082" length="8"/><text>patients</text></annotation><annotation id="22"><infon key="identifier">c|SUB|C|35322|C</infon><infon key="type">SequenceVariant</infon><location offset="1182" length="7"/><text>C35322C</text></annotation><annotation id="23"><infon key="identifier">D006973</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1223" length="12"/><text>hypertension</text></annotation><annotation id="24"><infon key="identifier">c|SUB|C|35322|T</infon><infon key="type">SequenceVariant</infon><location offset="1411" length="7"/><text>C35322T</text></annotation><annotation id="25"><infon key="identifier">D006973</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1442" length="12"/><text>hypertensive</text></annotation><annotation id="26"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1455" length="8"/><text>patients</text></annotation></passage><relation id="R0"><infon key="entity1">1558</infon><infon key="entity2">D006973</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D016718</infon><infon key="entity2">D006973</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">c|SUB|C|35322|T</infon><infon key="entity2">D006973</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">c|SUB|C|33468|T</infon><infon key="entity2">D006973</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">D006973</infon><infon key="entity2">c|SUB|C|35322|C</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">c|DEL|5063|T</infon><infon key="entity2">D006973</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>22711886</id><passage><infon key="type">title</infon><offset>0</offset><text>TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice.</text><annotation id="0"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="0" length="24"/><text>TNFR-associated factor 2</text></annotation><annotation id="1"><infon key="identifier">D015451</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="68" length="28"/><text>chronic lymphocytic leukemia</text></annotation><annotation id="2"><infon key="identifier">D015451</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="97" length="26"/><text>small lymphocytic lymphoma</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="127" length="4"/><text>mice</text></annotation></passage><passage><infon key="type">abstract</infon><offset>133</offset><text>We have previously shown that transgenic (tg) mice expressing in B lymphocytes both BCL-2 and a TNFR-associated factor 2 (TRAF2) mutant lacking the really interesting new gene and zinc finger domains (TRAF2DN) develop small lymphocytic lymphoma and chronic lymphocytic leukemia with high incidence (Zapata et al. 2004. Proc. Nat. Acad. Sci. USA 101: 16600-16605). Further analysis of the expression of TRAF2 and TRAF2DN in purified B cells demonstrated that expression of both endogenous TRAF2 and tg TRAF2DN was negligible in Traf2DN-tg B cells compared with wild-type mice. This was the result of proteasome-dependent degradation, and rendered TRAF2DN B cells as bona fide TRAF2-deficient B cells. Similar to B cells with targeted Traf2 deletion, Traf2DN-tg mice show expanded marginal zone B cell population and have constitutive p100 NF-kappaB2 processing. Also, TRAF3, X-linked inhibitor of apoptosis, and Bcl-X(L) expression levels were increased, whereas cellular inhibitors of apoptosis 1 and 2 levels were drastically reduced compared with those found in wild-type B cells. Moreover, consistent with previous results, we also show that TRAF2 was required for efficient JNK and ERK activation in response to CD40 engagement. However, TRAF2 was deleterious for BCR-mediated activation of these kinases. In contrast, TRAF2 deficiency had no effect on CD40-mediated p38 MAPK activation but significantly reduced BCR-mediated p38 activation. Finally, we further confirm that TRAF2 was required for CD40-mediated proliferation, but its absence relieved B cells of the need for B cell activating factor for survival. Altogether, our results suggest that TRAF2 deficiency cooperates with BCL-2 in promoting chronic lymphocytic leukemia/small lymphocytic lymphoma in mice, possibly by specifically enforcing marginal zone B cell accumulation, increasing X-linked inhibitor of apoptosis expression, and rendering B cells independent of B cell activating factor for survival.</text><annotation id="4"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="179" length="4"/><text>mice</text></annotation><annotation id="5"><infon key="identifier">596</infon><infon key="type">GeneOrGeneProduct</infon><location offset="217" length="5"/><text>BCL-2</text></annotation><annotation id="6"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="229" length="24"/><text>TNFR-associated factor 2</text></annotation><annotation id="7"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="255" length="5"/><text>TRAF2</text></annotation><annotation id="8"><infon key="identifier">D015451</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="351" length="26"/><text>small lymphocytic lymphoma</text></annotation><annotation id="9"><infon key="identifier">D015451</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="382" length="28"/><text>chronic lymphocytic leukemia</text></annotation><annotation id="10"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="535" length="5"/><text>TRAF2</text></annotation><annotation id="11"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="621" length="5"/><text>TRAF2</text></annotation><annotation id="12"><infon key="identifier">CVCL_TT54</infon><infon key="type">CellLine</infon><location offset="660" length="12"/><text>Traf2DN-tg B</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="703" length="4"/><text>mice</text></annotation><annotation id="14"><infon key="identifier">16912</infon><infon key="type">GeneOrGeneProduct</infon><location offset="732" length="10"/><text>proteasome</text></annotation><annotation id="15"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="808" length="5"/><text>TRAF2</text></annotation><annotation id="16"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="866" length="5"/><text>Traf2</text></annotation><annotation id="17"><infon key="identifier">CVCL_TT54</infon><infon key="type">CellLine</infon><location offset="882" length="10"/><text>Traf2DN-tg</text></annotation><annotation id="18"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="893" length="4"/><text>mice</text></annotation><annotation id="19"><infon key="identifier">18034</infon><infon key="type">GeneOrGeneProduct</infon><location offset="966" length="15"/><text>p100 NF-kappaB2</text></annotation><annotation id="20"><infon key="identifier">22031</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1000" length="5"/><text>TRAF3</text></annotation><annotation id="21"><infon key="identifier">11798</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1007" length="31"/><text>X-linked inhibitor of apoptosis</text></annotation><annotation id="22"><infon key="identifier">12048</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1044" length="8"/><text>Bcl-X(L)</text></annotation><annotation id="23"><infon key="identifier">11796,11797</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1095" length="40"/><text>cellular inhibitors of apoptosis 1 and 2</text></annotation><annotation id="24"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1278" length="5"/><text>TRAF2</text></annotation><annotation id="25"><infon key="identifier">26419</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1311" length="3"/><text>JNK</text></annotation><annotation id="26"><infon key="identifier">26413</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1319" length="3"/><text>ERK</text></annotation><annotation id="27"><infon key="identifier">21939</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1349" length="4"/><text>CD40</text></annotation><annotation id="28"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1375" length="5"/><text>TRAF2</text></annotation><annotation id="29"><infon key="identifier">12518</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1401" length="3"/><text>BCR</text></annotation><annotation id="30"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1456" length="5"/><text>TRAF2</text></annotation><annotation id="31"><infon key="identifier">21939</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1490" length="4"/><text>CD40</text></annotation><annotation id="32"><infon key="identifier">26416</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1504" length="8"/><text>p38 MAPK</text></annotation><annotation id="33"><infon key="identifier">12518</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1550" length="3"/><text>BCR</text></annotation><annotation id="34"><infon key="identifier">26416</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1563" length="3"/><text>p38</text></annotation><annotation id="35"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1612" length="5"/><text>TRAF2</text></annotation><annotation id="36"><infon key="identifier">21939</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1635" length="4"/><text>CD40</text></annotation><annotation id="37"><infon key="identifier">24099</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1713" length="24"/><text>B cell activating factor</text></annotation><annotation id="38"><infon key="identifier">22030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1789" length="5"/><text>TRAF2</text></annotation><annotation id="39"><infon key="identifier">596</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1822" length="5"/><text>BCL-2</text></annotation><annotation id="40"><infon key="identifier">D015451</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1841" length="28"/><text>chronic lymphocytic leukemia</text></annotation><annotation id="41"><infon key="identifier">D015451</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1870" length="26"/><text>small lymphocytic lymphoma</text></annotation><annotation id="42"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="1900" length="4"/><text>mice</text></annotation><annotation id="43"><infon key="identifier">11798</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1987" length="31"/><text>X-linked inhibitor of apoptosis</text></annotation><annotation id="44"><infon key="identifier">24099</infon><infon key="type">GeneOrGeneProduct</infon><location offset="2068" length="24"/><text>B cell activating factor</text></annotation></passage><relation id="R0"><infon key="entity1">596</infon><infon key="entity2">11798</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">596</infon><infon key="entity2">D015451</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">12518</infon><infon key="entity2">26416</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">21939</infon><infon key="entity2">26416</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R4"><infon key="entity1">26413</infon><infon key="entity2">21939</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">26419</infon><infon key="entity2">21939</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">22030</infon><infon key="entity2">24099</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">22030</infon><infon key="entity2">11798</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">22030</infon><infon key="entity2">596</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R9"><infon key="entity1">22030</infon><infon key="entity2">26416</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R10"><infon key="entity1">22030</infon><infon key="entity2">12518</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">22030</infon><infon key="entity2">21939</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R12"><infon key="entity1">22030</infon><infon key="entity2">26413</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R13"><infon key="entity1">22030</infon><infon key="entity2">26419</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R14"><infon key="entity1">22030</infon><infon key="entity2">D015451</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>24036311</id><passage><infon key="type">title</infon><offset>0</offset><text>CTR9/PAF1c regulates molecular lineage identity, histone H3K36 trimethylation and genomic imprinting during preimplantation development.</text><annotation id="0"><infon key="identifier">22083</infon><infon key="type">GeneOrGeneProduct</infon><location offset="0" length="4"/><text>CTR9</text></annotation><annotation id="1"><infon key="identifier">22083,54624,76246</infon><infon key="type">GeneOrGeneProduct</infon><location offset="5" length="5"/><text>PAF1c</text></annotation><annotation id="2"><infon key="identifier">260423</infon><infon key="type">GeneOrGeneProduct</infon><location offset="49" length="10"/><text>histone H3</text></annotation></passage><passage><infon key="type">abstract</infon><offset>137</offset><text>Genome-wide epigenetic reprogramming is required for successful preimplantation development. Inappropriate or deficient chromatin regulation can result in defective lineage specification and loss of genomic imprinting, compromising normal development. Here we report that two members of the RNA polymerase II associated factor, homolog (Saccharomyces cerevisiae) complex (PAF1 complex) components, Ctr9 and Rtf1, are required during mammalian preimplantation development. We demonstrate that Ctr9-deficient embryos fail to correctly specify lineages at the blastocyst stage. Expression of some lineage specific factors is markedly reduced in Ctr9 knockdown embryos, including Eomes, Elf5 and Sox2, while others are inappropriately expressed (Oct4, Nanog, Gata6, Fgf4 and Sox17). We also show that several imprinted genes (Mest, Peg3, Snrpn and Meg3) are aberrantly expressed although allele specific DNA methylation is not altered. We document a loss of histone H3 lysine 36 trimethylation (H3K36me3) in Ctr9-deficient embryos and confirm that knockdown of either Setd2 or Rtf1 results in similar phenotypes. These findings show that the PAF1 complex is required for mammalian development, likely through regulation of H3K36me3, and indicate functional conservation of the PAF1 complex from yeast to mammals in vivo.</text><annotation id="3"><infon key="identifier">22083,54624,76246</infon><infon key="type">GeneOrGeneProduct</infon><location offset="428" length="79"/><text>RNA polymerase II associated factor, homolog (Saccharomyces cerevisiae) complex</text></annotation><annotation id="4"><infon key="identifier">22083,54624,76246</infon><infon key="type">GeneOrGeneProduct</infon><location offset="509" length="12"/><text>PAF1 complex</text></annotation><annotation id="5"><infon key="identifier">22083</infon><infon key="type">GeneOrGeneProduct</infon><location offset="535" length="4"/><text>Ctr9</text></annotation><annotation id="6"><infon key="identifier">76246</infon><infon key="type">GeneOrGeneProduct</infon><location offset="544" length="4"/><text>Rtf1</text></annotation><annotation id="7"><infon key="identifier">22083</infon><infon key="type">GeneOrGeneProduct</infon><location offset="629" length="4"/><text>Ctr9</text></annotation><annotation id="8"><infon key="identifier">22083</infon><infon key="type">GeneOrGeneProduct</infon><location offset="779" length="4"/><text>Ctr9</text></annotation><annotation id="9"><infon key="identifier">13813</infon><infon key="type">GeneOrGeneProduct</infon><location offset="813" length="5"/><text>Eomes</text></annotation><annotation id="10"><infon key="identifier">13711</infon><infon key="type">GeneOrGeneProduct</infon><location offset="820" length="4"/><text>Elf5</text></annotation><annotation id="11"><infon key="identifier">20674</infon><infon key="type">GeneOrGeneProduct</infon><location offset="829" length="4"/><text>Sox2</text></annotation><annotation id="12"><infon key="identifier">18999</infon><infon key="type">GeneOrGeneProduct</infon><location offset="879" length="4"/><text>Oct4</text></annotation><annotation id="13"><infon key="identifier">71950</infon><infon key="type">GeneOrGeneProduct</infon><location offset="885" length="5"/><text>Nanog</text></annotation><annotation id="14"><infon key="identifier">14465</infon><infon key="type">GeneOrGeneProduct</infon><location offset="892" length="5"/><text>Gata6</text></annotation><annotation id="15"><infon key="identifier">14175</infon><infon key="type">GeneOrGeneProduct</infon><location offset="899" length="4"/><text>Fgf4</text></annotation><annotation id="16"><infon key="identifier">20671</infon><infon key="type">GeneOrGeneProduct</infon><location offset="908" length="5"/><text>Sox17</text></annotation><annotation id="17"><infon key="identifier">17294</infon><infon key="type">GeneOrGeneProduct</infon><location offset="959" length="4"/><text>Mest</text></annotation><annotation id="18"><infon key="identifier">18616</infon><infon key="type">GeneOrGeneProduct</infon><location offset="965" length="4"/><text>Peg3</text></annotation><annotation id="19"><infon key="identifier">20646</infon><infon key="type">GeneOrGeneProduct</infon><location offset="971" length="5"/><text>Snrpn</text></annotation><annotation id="20"><infon key="identifier">17263</infon><infon key="type">GeneOrGeneProduct</infon><location offset="981" length="4"/><text>Meg3</text></annotation><annotation id="21"><infon key="identifier">260423</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1091" length="10"/><text>histone H3</text></annotation><annotation id="22"><infon key="identifier">260423</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1128" length="2"/><text>H3</text></annotation><annotation id="23"><infon key="identifier">22083</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1141" length="4"/><text>Ctr9</text></annotation><annotation id="24"><infon key="identifier">235626</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1201" length="5"/><text>Setd2</text></annotation><annotation id="25"><infon key="identifier">76246</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1210" length="4"/><text>Rtf1</text></annotation><annotation id="26"><infon key="identifier">22083,54624,76246</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1275" length="12"/><text>PAF1 complex</text></annotation><annotation id="27"><infon key="identifier">260423</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1356" length="2"/><text>H3</text></annotation><annotation id="28"><infon key="identifier">22083,54624,76246</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1410" length="12"/><text>PAF1 complex</text></annotation><annotation id="29"><infon key="identifier">4932</infon><infon key="type">OrganismTaxon</infon><location offset="1428" length="5"/><text>yeast</text></annotation></passage><relation id="R0"><infon key="entity1">235626</infon><infon key="entity2">260423</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">76246</infon><infon key="entity2">260423</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">54624</infon><infon key="entity2">260423</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">22083</infon><infon key="entity2">17263</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">22083</infon><infon key="entity2">20646</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">22083</infon><infon key="entity2">18616</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">22083</infon><infon key="entity2">17294</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">22083</infon><infon key="entity2">20671</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">22083</infon><infon key="entity2">14175</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R9"><infon key="entity1">22083</infon><infon key="entity2">14465</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R10"><infon key="entity1">22083</infon><infon key="entity2">71950</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">22083</infon><infon key="entity2">18999</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R12"><infon key="entity1">22083</infon><infon key="entity2">20674</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R13"><infon key="entity1">22083</infon><infon key="entity2">13711</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R14"><infon key="entity1">22083</infon><infon key="entity2">13813</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R15"><infon key="entity1">22083</infon><infon key="entity2">260423</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R16"><infon key="entity1">22083</infon><infon key="entity2">76246</infon><infon key="type">Bind</infon><infon key="novel">No</infon></relation><relation id="R17"><infon key="entity1">22083</infon><infon key="entity2">54624</infon><infon key="type">Bind</infon><infon key="novel">No</infon></relation><relation id="R18"><infon key="entity1">22083</infon><infon key="entity2">22083</infon><infon key="type">Bind</infon><infon key="novel">No</infon></relation></document><document><id>25080425</id><passage><infon key="type">title</infon><offset>0</offset><text>Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats.</text><annotation id="0"><infon key="identifier">25125</infon><infon key="type">GeneOrGeneProduct</infon><location offset="14" length="50"/><text>signal transducer and activator of transcription 3</text></annotation><annotation id="1"><infon key="identifier">D001622</infon><infon key="type">ChemicalEntity</infon><location offset="91" length="7"/><text>betaine</text></annotation><annotation id="2"><infon key="identifier">D007545</infon><infon key="type">ChemicalEntity</infon><location offset="110" length="13"/><text>isoproterenol</text></annotation><annotation id="3"><infon key="identifier">D009202</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="138" length="17"/><text>myocardial injury</text></annotation><annotation id="4"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="159" length="4"/><text>rats</text></annotation></passage><passage><infon key="type">abstract</infon><offset>165</offset><text>The present study was designed to investigate the cardioprotective effects of betaine on acute myocardial ischemia induced experimentally in rats focusing on regulation of signal transducer and activator of transcription 3 (STAT3) and apoptotic pathways as the potential mechanism underlying the drug effect. Male Sprague Dawley rats were treated with betaine (100, 200, and 400 mg/kg) orally for 40 days. Acute myocardial ischemic injury was induced in rats by subcutaneous injection of isoproterenol (85 mg/kg), for two consecutive days. Serum cardiac marker enzyme, histopathological variables and expression of protein levels were analyzed. Oral administration of betaine (200 and 400 mg/kg) significantly reduced the level of cardiac marker enzyme in the serum and prevented left ventricular remodeling. Western blot analysis showed that isoproterenol-induced phosphorylation of STAT3 was maintained or further enhanced by betaine treatment in myocardium. Furthermore, betaine (200 and 400 mg/kg) treatment increased the ventricular expression of Bcl-2 and reduced the level of Bax, therefore causing a significant increase in the ratio of Bcl-2/Bax. The protective role of betaine on myocardial damage was further confirmed by histopathological examination. In summary, our results showed that betaine pretreatment attenuated isoproterenol-induced acute myocardial ischemia via the regulation of STAT3 and apoptotic pathways.</text><annotation id="5"><infon key="identifier">D001622</infon><infon key="type">ChemicalEntity</infon><location offset="243" length="7"/><text>betaine</text></annotation><annotation id="6"><infon key="identifier">D017202</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="260" length="19"/><text>myocardial ischemia</text></annotation><annotation id="7"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="306" length="4"/><text>rats</text></annotation><annotation id="8"><infon key="identifier">25125</infon><infon key="type">GeneOrGeneProduct</infon><location offset="337" length="50"/><text>signal transducer and activator of transcription 3</text></annotation><annotation id="9"><infon key="identifier">25125</infon><infon key="type">GeneOrGeneProduct</infon><location offset="389" length="5"/><text>STAT3</text></annotation><annotation id="10"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="494" length="4"/><text>rats</text></annotation><annotation id="11"><infon key="identifier">D001622</infon><infon key="type">ChemicalEntity</infon><location offset="517" length="7"/><text>betaine</text></annotation><annotation id="12"><infon key="identifier">D017202</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="577" length="26"/><text>myocardial ischemic injury</text></annotation><annotation id="13"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="619" length="4"/><text>rats</text></annotation><annotation id="14"><infon key="identifier">D007545</infon><infon key="type">ChemicalEntity</infon><location offset="653" length="13"/><text>isoproterenol</text></annotation><annotation id="15"><infon key="identifier">D001622</infon><infon key="type">ChemicalEntity</infon><location offset="833" length="7"/><text>betaine</text></annotation><annotation id="16"><infon key="identifier">D020257</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="950" length="22"/><text>ventricular remodeling</text></annotation><annotation id="17"><infon key="identifier">D007545</infon><infon key="type">ChemicalEntity</infon><location offset="1008" length="13"/><text>isoproterenol</text></annotation><annotation id="18"><infon key="identifier">25125</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1049" length="5"/><text>STAT3</text></annotation><annotation id="19"><infon key="identifier">D001622</infon><infon key="type">ChemicalEntity</infon><location offset="1093" length="7"/><text>betaine</text></annotation><annotation id="20"><infon key="identifier">D001622</infon><infon key="type">ChemicalEntity</infon><location offset="1139" length="7"/><text>betaine</text></annotation><annotation id="21"><infon key="identifier">24224</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1217" length="5"/><text>Bcl-2</text></annotation><annotation id="22"><infon key="identifier">24887</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1248" length="3"/><text>Bax</text></annotation><annotation id="23"><infon key="identifier">24224</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1310" length="5"/><text>Bcl-2</text></annotation><annotation id="24"><infon key="identifier">24887</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1316" length="3"/><text>Bax</text></annotation><annotation id="25"><infon key="identifier">D001622</infon><infon key="type">ChemicalEntity</infon><location offset="1344" length="7"/><text>betaine</text></annotation><annotation id="26"><infon key="identifier">D009202</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1355" length="17"/><text>myocardial damage</text></annotation><annotation id="27"><infon key="identifier">D001622</infon><infon key="type">ChemicalEntity</infon><location offset="1465" length="7"/><text>betaine</text></annotation><annotation id="28"><infon key="identifier">D007545</infon><infon key="type">ChemicalEntity</infon><location offset="1497" length="13"/><text>isoproterenol</text></annotation><annotation id="29"><infon key="identifier">D017202</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1525" length="19"/><text>myocardial ischemia</text></annotation><annotation id="30"><infon key="identifier">25125</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1567" length="5"/><text>STAT3</text></annotation></passage><relation id="R0"><infon key="entity1">D017202</infon><infon key="entity2">D007545</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">D017202</infon><infon key="entity2">25125</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">D007545</infon><infon key="entity2">D009202</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">D007545</infon><infon key="entity2">25125</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">D009202</infon><infon key="entity2">25125</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">D001622</infon><infon key="entity2">24887</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">D001622</infon><infon key="entity2">24224</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">D001622</infon><infon key="entity2">D020257</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">D001622</infon><infon key="entity2">D017202</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R9"><infon key="entity1">D001622</infon><infon key="entity2">D007545</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R10"><infon key="entity1">D001622</infon><infon key="entity2">D009202</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">D001622</infon><infon key="entity2">25125</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>27509880</id><passage><infon key="type">title</infon><offset>0</offset><text>Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.</text><annotation id="0"><infon key="identifier">3065</infon><infon key="type">GeneOrGeneProduct</infon><location offset="19" length="19"/><text>histone deacetylase</text></annotation><annotation id="1"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="49" length="12"/><text>depsipeptide</text></annotation><annotation id="2"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="66" length="14"/><text>5-fluorouracil</text></annotation><annotation id="3"><infon key="identifier">3119</infon><infon key="type">GeneOrGeneProduct</infon><location offset="93" length="41"/><text>major histocompatibility complex class II</text></annotation><annotation id="4"><infon key="identifier">1026</infon><infon key="type">GeneOrGeneProduct</infon><location offset="139" length="3"/><text>p21</text></annotation><annotation id="5"><infon key="identifier">836,840</infon><infon key="type">GeneOrGeneProduct</infon><location offset="163" length="11"/><text>caspase-3/7</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="178" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">D003110</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="184" length="12"/><text>colon cancer</text></annotation><annotation id="8"><infon key="identifier">CVCL_0291</infon><infon key="type">CellLine</infon><location offset="197" length="7"/><text>HCT-116</text></annotation></passage><passage><infon key="type">abstract</infon><offset>212</offset><text>Epigenetic anticancer drugs such as histone deacetylase (HDAC) inhibitors have been combined with existing anticancer drugs for synergistic or additive effects. In the present study, we found that a very low concentration of depsipeptide, an HDAC inhibitor, potentiated the antitumor activity of 5-fluorouracil (5-FU) in a human colon cancer cell model using HCT-116, HT29, and SW48 cells via the inhibition of colony formation ability or cellular viability. Exposure to a combination of 5-FU (1.75 uM) and 1 nM depsipeptide for 24 and 48 h resulted in a 3- to 4-fold increase in activated caspase-3/7, while 5-FU alone failed to activate caspase-3/7. Microarray and subsequent gene ontology analyses revealed that compared to 5-FU or depsipeptide alone, the combination treatment of 5-FU and depsipeptide upregulated genes related to cell death and the apoptotic process consistent with the inhibition of colony formation and caspase-3/7 activation. These analyses indicated marked upregulation of antigen processing and presentation of peptide or polysaccharide antigen via major histocompatibility complex (MHC) class (GO:0002504) and MHC protein complex (GO:0042611). Compared with vehicle controls, the cells treated with the combination of 5-FU and depsipeptide showed marked induction (3- to 8.5-fold) of expression of MHC class II genes, but not of MHC class I genes. Furthermore, our global analysis of gene expression, which was focused on genes involved in the molecular regulation of MHC class II genes, showed enhancement of pro-apoptotic PCAF and CIITA after the combination of 5-FU and depsipeptide. These results may indicate a closer relationship between elevation of MHC class II expression and cellular apoptosis induced by the combination of depsipeptide and 5-FU. To the best of our knowledge, this is the first study to report that the combination of 5-FU and depsipeptide induces human colon cancer cell apoptosis in a concerted manner with the induction of MHC class II gene expression.</text><annotation id="9"><infon key="identifier">3065</infon><infon key="type">GeneOrGeneProduct</infon><location offset="248" length="19"/><text>histone deacetylase</text></annotation><annotation id="10"><infon key="identifier">3065</infon><infon key="type">GeneOrGeneProduct</infon><location offset="269" length="4"/><text>HDAC</text></annotation><annotation id="11"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="437" length="12"/><text>depsipeptide</text></annotation><annotation id="12"><infon key="identifier">3065</infon><infon key="type">GeneOrGeneProduct</infon><location offset="454" length="4"/><text>HDAC</text></annotation><annotation id="13"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="508" length="14"/><text>5-fluorouracil</text></annotation><annotation id="14"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="524" length="4"/><text>5-FU</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="535" length="5"/><text>human</text></annotation><annotation id="16"><infon key="identifier">D003110</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="541" length="12"/><text>colon cancer</text></annotation><annotation id="17"><infon key="identifier">CVCL_0291</infon><infon key="type">CellLine</infon><location offset="571" length="7"/><text>HCT-116</text></annotation><annotation id="18"><infon key="identifier">CVCL_0320</infon><infon key="type">CellLine</infon><location offset="580" length="4"/><text>HT29</text></annotation><annotation id="19"><infon key="identifier">CVCL_1724</infon><infon key="type">CellLine</infon><location offset="590" length="4"/><text>SW48</text></annotation><annotation id="20"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="700" length="4"/><text>5-FU</text></annotation><annotation id="21"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="724" length="12"/><text>depsipeptide</text></annotation><annotation id="22"><infon key="identifier">836,840</infon><infon key="type">GeneOrGeneProduct</infon><location offset="802" length="11"/><text>caspase-3/7</text></annotation><annotation id="23"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="821" length="4"/><text>5-FU</text></annotation><annotation id="24"><infon key="identifier">836,840</infon><infon key="type">GeneOrGeneProduct</infon><location offset="851" length="11"/><text>caspase-3/7</text></annotation><annotation id="25"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="939" length="4"/><text>5-FU</text></annotation><annotation id="26"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="947" length="12"/><text>depsipeptide</text></annotation><annotation id="27"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="996" length="4"/><text>5-FU</text></annotation><annotation id="28"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="1005" length="12"/><text>depsipeptide</text></annotation><annotation id="29"><infon key="identifier">836,840</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1139" length="11"/><text>caspase-3/7</text></annotation><annotation id="30"><infon key="identifier">D011134</infon><infon key="type">ChemicalEntity</infon><location offset="1261" length="14"/><text>polysaccharide</text></annotation><annotation id="31"><infon key="identifier">3123</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1288" length="44"/><text>major histocompatibility complex (MHC) class</text></annotation><annotation id="32"><infon key="identifier">3123</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1350" length="19"/><text>MHC protein complex</text></annotation><annotation id="33"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="1458" length="4"/><text>5-FU</text></annotation><annotation id="34"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="1467" length="12"/><text>depsipeptide</text></annotation><annotation id="35"><infon key="identifier">3119</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1538" length="18"/><text>MHC class II genes</text></annotation><annotation id="36"><infon key="identifier">3106</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1569" length="17"/><text>MHC class I genes</text></annotation><annotation id="37"><infon key="identifier">3119</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1708" length="18"/><text>MHC class II genes</text></annotation><annotation id="38"><infon key="identifier">8850</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1764" length="4"/><text>PCAF</text></annotation><annotation id="39"><infon key="identifier">4261</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1773" length="5"/><text>CIITA</text></annotation><annotation id="40"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="1804" length="4"/><text>5-FU</text></annotation><annotation id="41"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="1813" length="12"/><text>depsipeptide</text></annotation><annotation id="42"><infon key="identifier">3119</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1897" length="12"/><text>MHC class II</text></annotation><annotation id="43"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="1974" length="12"/><text>depsipeptide</text></annotation><annotation id="44"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="1991" length="4"/><text>5-FU</text></annotation><annotation id="45"><infon key="identifier">D005472</infon><infon key="type">ChemicalEntity</infon><location offset="2085" length="4"/><text>5-FU</text></annotation><annotation id="46"><infon key="identifier">D047630</infon><infon key="type">ChemicalEntity</infon><location offset="2094" length="12"/><text>depsipeptide</text></annotation><annotation id="47"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="2115" length="5"/><text>human</text></annotation><annotation id="48"><infon key="identifier">D003110</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="2121" length="12"/><text>colon cancer</text></annotation><annotation id="49"><infon key="identifier">3119</infon><infon key="type">GeneOrGeneProduct</infon><location offset="2193" length="12"/><text>MHC class II</text></annotation></passage><relation id="R0"><infon key="entity1">D011134</infon><infon key="entity2">3123</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">3065</infon><infon key="entity2">D047630</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">D005472</infon><infon key="entity2">D003110</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">D005472</infon><infon key="entity2">4261</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">D005472</infon><infon key="entity2">8850</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">D005472</infon><infon key="entity2">1026</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">840</infon><infon key="entity2">D005472</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">840</infon><infon key="entity2">D047630</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">836</infon><infon key="entity2">D005472</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R9"><infon key="entity1">836</infon><infon key="entity2">D047630</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R10"><infon key="entity1">D047630</infon><infon key="entity2">D003110</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">D047630</infon><infon key="entity2">4261</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R12"><infon key="entity1">D047630</infon><infon key="entity2">8850</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R13"><infon key="entity1">D047630</infon><infon key="entity2">D005472</infon><infon key="type">Cotreatment</infon><infon key="novel">No</infon></relation><relation id="R14"><infon key="entity1">D047630</infon><infon key="entity2">1026</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R15"><infon key="entity1">3119</infon><infon key="entity2">D005472</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R16"><infon key="entity1">3119</infon><infon key="entity2">D047630</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>27840894</id><passage><infon key="type">title</infon><offset>0</offset><text>Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets.</text><annotation id="0"><infon key="identifier">5251</infon><infon key="type">GeneOrGeneProduct</infon><location offset="28" length="4"/><text>PHEX</text></annotation><annotation id="1"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="51" length="8"/><text>patients</text></annotation><annotation id="2"><infon key="identifier">D063730</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="65" length="24"/><text>hypophosphatemic rickets</text></annotation></passage><passage><infon key="type">abstract</infon><offset>91</offset><text>Inactivating mutations in phosphate-regulating gene with homologies to endopeptidase on the X chromosome (PHEX) have been identified as a cause of X-linked hypophosphatemic rickets (XLH; OMIM 307800). In the present study, we enrolled 43 patients from 18 unrelated families clinically diagnosed with hypophosphatemic rickets and 250 healthy controls. For each available individual, all 22 exons with their exon-intron boundaries of the PHEX gene were directly sequenced. The levels of serum fibroblast growth factor 23 (FGF23) were measured as well. Sequencing analysis detected 17 different PHEX gene mutations, and 7 of these were identified as novel: 3 missense mutations, including c.304G>A (p.Gly102Arg) in exon 3, c.229T>C (p.Cys77Arg) in exon 3 and c.824T>C (p.Leu275Pro) in exon 7; 2 deletion mutations, including c.528delT (p.Glu177LysfsX44) in exon 5 and c.1234delA (p.Ser412ValfsX12) in exon 11; and 2 alternative splicing mutations, including c.436_436+1delAG in intron 4 at splicing donor sites and c.1483-1G>C in intron 13 at splicing acceptor sites. Moreover, 6 mutations were proven to be de novo in 6 sporadic cases and the probands were all females. No mutations were found in the 250 healthy controls. The serum levels of FGF23 varied widely among the patients with XLH, and no significant difference was found when compared with those of the healthy controls. On the whole, the findings of this study provide new insight into the spectrum of PHEX mutations and provide potential evidence of a critical domain in PHEX protein. In addition, the finding of an overlap of the serum FGF23 levels between the patients with XLH and the healthy controls indicates its limited diagnostic value in XLH.</text><annotation id="3"><infon key="identifier">5251</infon><infon key="type">GeneOrGeneProduct</infon><location offset="117" length="78"/><text>phosphate-regulating gene with homologies to endopeptidase on the X chromosome</text></annotation><annotation id="4"><infon key="identifier">5251</infon><infon key="type">GeneOrGeneProduct</infon><location offset="197" length="4"/><text>PHEX</text></annotation><annotation id="5"><infon key="identifier">D053098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="238" length="33"/><text>X-linked hypophosphatemic rickets</text></annotation><annotation id="6"><infon key="identifier">D053098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="273" length="3"/><text>XLH</text></annotation><annotation id="7"><infon key="identifier">D053098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="278" length="11"/><text>OMIM 307800</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="329" length="8"/><text>patients</text></annotation><annotation id="9"><infon key="identifier">D063730</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="391" length="24"/><text>hypophosphatemic rickets</text></annotation><annotation id="10"><infon key="identifier">5251</infon><infon key="type">GeneOrGeneProduct</infon><location offset="527" length="4"/><text>PHEX</text></annotation><annotation id="11"><infon key="identifier">8074</infon><infon key="type">GeneOrGeneProduct</infon><location offset="582" length="27"/><text>fibroblast growth factor 23</text></annotation><annotation id="12"><infon key="identifier">8074</infon><infon key="type">GeneOrGeneProduct</infon><location offset="611" length="5"/><text>FGF23</text></annotation><annotation id="13"><infon key="identifier">5251</infon><infon key="type">GeneOrGeneProduct</infon><location offset="683" length="4"/><text>PHEX</text></annotation><annotation id="14"><infon key="identifier">c|SUB|G|304|A</infon><infon key="type">SequenceVariant</infon><location offset="777" length="8"/><text>c.304G>A</text></annotation><annotation id="15"><infon key="identifier">p|SUB|G|102|R</infon><infon key="type">SequenceVariant</infon><location offset="787" length="11"/><text>p.Gly102Arg</text></annotation><annotation id="16"><infon key="identifier">c|SUB|T|229|C</infon><infon key="type">SequenceVariant</infon><location offset="811" length="8"/><text>c.229T>C</text></annotation><annotation id="17"><infon key="identifier">p|SUB|C|77|R</infon><infon key="type">SequenceVariant</infon><location offset="821" length="10"/><text>p.Cys77Arg</text></annotation><annotation id="18"><infon key="identifier">c|SUB|T|284|C</infon><infon key="type">SequenceVariant</infon><location offset="847" length="8"/><text>c.824T>C</text></annotation><annotation id="19"><infon key="identifier">p|SUB|L|275|P</infon><infon key="type">SequenceVariant</infon><location offset="857" length="11"/><text>p.Leu275Pro</text></annotation><annotation id="20"><infon key="identifier">c|DEL|528|T</infon><infon key="type">SequenceVariant</infon><location offset="913" length="9"/><text>c.528delT</text></annotation><annotation id="21"><infon key="identifier">p|SUB|E|177|K|44</infon><infon key="type">SequenceVariant</infon><location offset="924" length="16"/><text>p.Glu177LysfsX44</text></annotation><annotation id="22"><infon key="identifier">c|DEL|1234|A</infon><infon key="type">SequenceVariant</infon><location offset="956" length="10"/><text>c.1234delA</text></annotation><annotation id="23"><infon key="identifier">p|SUB|S|412|V|12</infon><infon key="type">SequenceVariant</infon><location offset="968" length="16"/><text>p.Ser412ValfsX12</text></annotation><annotation id="24"><infon key="identifier">c|DEL|436_436+1|AG</infon><infon key="type">SequenceVariant</infon><location offset="1046" length="16"/><text>c.436_436+1delAG</text></annotation><annotation id="25"><infon key="identifier">c|SUB|G|1483-1|C</infon><infon key="type">SequenceVariant</infon><location offset="1103" length="11"/><text>c.1483-1G>C</text></annotation><annotation id="26"><infon key="identifier">8074</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1332" length="5"/><text>FGF23</text></annotation><annotation id="27"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1362" length="8"/><text>patients</text></annotation><annotation id="28"><infon key="identifier">D053098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1376" length="3"/><text>XLH</text></annotation><annotation id="29"><infon key="identifier">5251</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1553" length="4"/><text>PHEX</text></annotation><annotation id="30"><infon key="identifier">5251</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1623" length="4"/><text>PHEX</text></annotation><annotation id="31"><infon key="identifier">8074</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1689" length="5"/><text>FGF23</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1714" length="8"/><text>patients</text></annotation><annotation id="33"><infon key="identifier">D053098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1728" length="3"/><text>XLH</text></annotation><annotation id="34"><infon key="identifier">D053098</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1799" length="3"/><text>XLH</text></annotation></passage><relation id="R0"><infon key="entity1">D053098</infon><infon key="entity2">c|SUB|G|1483-1|C</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D053098</infon><infon key="entity2">c|SUB|G|304|A</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">D053098</infon><infon key="entity2">c|SUB|T|229|C</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">D053098</infon><infon key="entity2">c|SUB|T|284|C</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">D053098</infon><infon key="entity2">c|DEL|436_436+1|AG</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">D053098</infon><infon key="entity2">p|SUB|S|412|V|12</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">D053098</infon><infon key="entity2">c|DEL|1234|A</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">D053098</infon><infon key="entity2">p|SUB|E|177|K|44</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">D053098</infon><infon key="entity2">c|DEL|528|T</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R9"><infon key="entity1">D053098</infon><infon key="entity2">p|SUB|L|275|P</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R10"><infon key="entity1">D053098</infon><infon key="entity2">p|SUB|C|77|R</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">D053098</infon><infon key="entity2">p|SUB|G|102|R</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R12"><infon key="entity1">D063730</infon><infon key="entity2">c|SUB|G|1483-1|C</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R13"><infon key="entity1">D063730</infon><infon key="entity2">c|SUB|G|304|A</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R14"><infon key="entity1">D063730</infon><infon key="entity2">c|SUB|T|229|C</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R15"><infon key="entity1">D063730</infon><infon key="entity2">c|SUB|T|284|C</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R16"><infon key="entity1">D063730</infon><infon key="entity2">c|DEL|436_436+1|AG</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R17"><infon key="entity1">D063730</infon><infon key="entity2">p|SUB|S|412|V|12</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R18"><infon key="entity1">D063730</infon><infon key="entity2">c|DEL|1234|A</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R19"><infon key="entity1">D063730</infon><infon key="entity2">p|SUB|E|177|K|44</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R20"><infon key="entity1">D063730</infon><infon key="entity2">c|DEL|528|T</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R21"><infon key="entity1">D063730</infon><infon key="entity2">p|SUB|L|275|P</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R22"><infon key="entity1">D063730</infon><infon key="entity2">p|SUB|C|77|R</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R23"><infon key="entity1">D063730</infon><infon key="entity2">p|SUB|G|102|R</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R24"><infon key="entity1">5251</infon><infon key="entity2">D053098</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R25"><infon key="entity1">5251</infon><infon key="entity2">D063730</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation></document><document><id>6086495</id><passage><infon key="type">title</infon><offset>0</offset><text>Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences.</text><annotation id="0"><infon key="identifier">1756</infon><infon key="type">GeneOrGeneProduct</infon><location offset="20" length="30"/><text>Becker muscular dystrophy gene</text></annotation></passage><passage><infon key="type">abstract</infon><offset>124</offset><text>A linkage study in 30 Becker muscular dystrophy (BMD) kindreds using three cloned DNA sequences from the X chromosome which demonstrate restriction fragment length polymorphisms (RFLPs), suggests that the BMD gene is located on the short arm of the X chromosome, in the p21 region. The genes for Becker and Duchenne dystrophies must therefore be closely linked, if not allelic, and any future DNA probes found to be of practical use in one disorder should be equally applicable to the other. The linkage analysis also provides data on the frequency of recombination along the short arm of the X chromosome, and across the centromeric region.. </text><annotation id="1"><infon key="identifier">D020388</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="146" length="25"/><text>Becker muscular dystrophy</text></annotation><annotation id="2"><infon key="identifier">D020388</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="173" length="3"/><text>BMD</text></annotation><annotation id="3"><infon key="identifier">1756</infon><infon key="type">GeneOrGeneProduct</infon><location offset="329" length="3"/><text>BMD</text></annotation><annotation id="4"><infon key="identifier">D020388</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="420" length="31"/><text>Becker and Duchenne dystrophies</text></annotation></passage><relation id="R0"><infon key="entity1">1756</infon><infon key="entity2">D020388</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>7811247</id><passage><infon key="type">title</infon><offset>0</offset><text>X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes.</text><annotation id="0"><infon key="identifier">D000326</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="0" length="29"/><text>X-linked adrenoleukodystrophy</text></annotation><annotation id="1"><infon key="identifier">D000326</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="31" length="3"/><text>ALD</text></annotation><annotation id="2"><infon key="identifier">215</infon><infon key="type">GeneOrGeneProduct</infon><location offset="61" length="3"/><text>ALD</text></annotation></passage><passage><infon key="type">abstract</infon><offset>135</offset><text>Fragments of the adrenoleukodystrophy (ALD) cDNA from a patient with adolescent ALD were amplified by polymerase chain reaction and subcloned. Bidirectional sequencing of the entire coding ALD gene disclosed a cytosine to guanine transversion at nucleotide 1451 in exon five, resulting in substitution of proline 484 by arginine. Five of nine siblings of the patient, comprising two cerebral ALD, one adrenomyeloneuropathy, one Addison only as well as the symptomatic mother (all accumulating very long chain fatty acids) carried this mutation, which was not found in the unaffected persons, in five unrelated ALD patients, and in twenty controls. We propose that this missense mutation generated the disease per se as well as the metabolic defect; the different phenotypes, however, must have originated by means of additional pathogenetic factors.. </text><annotation id="3"><infon key="identifier">D000326</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="152" length="20"/><text>adrenoleukodystrophy</text></annotation><annotation id="4"><infon key="identifier">D000326</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="174" length="3"/><text>ALD</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="191" length="7"/><text>patient</text></annotation><annotation id="6"><infon key="identifier">D000326</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="215" length="3"/><text>ALD</text></annotation><annotation id="7"><infon key="identifier">215</infon><infon key="type">GeneOrGeneProduct</infon><location offset="324" length="3"/><text>ALD</text></annotation><annotation id="8"><infon key="identifier">rs128624214</infon><infon key="type">SequenceVariant</infon><location offset="345" length="51"/><text>cytosine to guanine transversion at nucleotide 1451</text></annotation><annotation id="9"><infon key="identifier">rs128624214</infon><infon key="type">SequenceVariant</infon><location offset="440" length="23"/><text>proline 484 by arginine</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="494" length="7"/><text>patient</text></annotation><annotation id="11"><infon key="identifier">D000326</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="527" length="3"/><text>ALD</text></annotation><annotation id="12"><infon key="identifier">D000326</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="536" length="21"/><text>adrenomyeloneuropathy</text></annotation><annotation id="13"><infon key="identifier">D000224</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="563" length="7"/><text>Addison</text></annotation><annotation id="14"><infon key="identifier">D005227</infon><infon key="type">ChemicalEntity</infon><location offset="633" length="22"/><text>long chain fatty acids</text></annotation><annotation id="15"><infon key="identifier">D000326</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="745" length="3"/><text>ALD</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="749" length="8"/><text>patients</text></annotation></passage><relation id="R0"><infon key="entity1">215</infon><infon key="entity2">D000224</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">D000326</infon><infon key="entity2">215</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">rs128624214</infon><infon key="entity2">D000326</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">rs128624214</infon><infon key="entity2">D000224</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>8944024</id><passage><infon key="type">title</infon><offset>0</offset><text>Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis.</text><annotation id="0"><infon key="identifier">672</infon><infon key="type">GeneOrGeneProduct</infon><location offset="39" length="5"/><text>BRCA1</text></annotation></passage><passage><infon key="type">abstract</infon><offset>125</offset><text>The ability to scan a large gene rapidly and accurately for all possible heterozygous mutations in large numbers of patient samples will be critical for the future of medicine. We have designed high-density arrays consisting of over 96, 600 oligonucleotides 20-nucleotides (nt) in length to screen for a wide range of heterozygous mutations in the 3. 45-kilobases (kb) exon 11 of the hereditary breast and ovarian cancer gene BRCA1. Reference and test samples were co-hybridized to these arrays and differences in hybridization patterns quantitated by two-colour analysis. Fourteen of fifteen patient samples with known mutations were accurately diagnosed, and no false positive mutations were identified in 20 control samples. Eight single nucleotide polymorphisms were also readily detected. DNA chip-based assays may provide a valuable new technology for high-throughput cost-efficient detection of genetic alterations. </text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="241" length="7"/><text>patient</text></annotation><annotation id="2"><infon key="identifier">672</infon><infon key="type">GeneOrGeneProduct</infon><location offset="520" length="30"/><text>breast and ovarian cancer gene</text></annotation><annotation id="3"><infon key="identifier">672</infon><infon key="type">GeneOrGeneProduct</infon><location offset="551" length="5"/><text>BRCA1</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="718" length="7"/><text>patient</text></annotation></passage></document><document><id>16838170</id><passage><infon key="type">title</infon><offset>0</offset><text>Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial.</text><annotation id="0"><infon key="identifier">3172</infon><infon key="type">GeneOrGeneProduct</infon><location offset="39" length="9"/><text>HNF4alpha</text></annotation><annotation id="1"><infon key="identifier">D003924</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="92" length="24"/><text>type 2 diabetes mellitus</text></annotation></passage><passage><infon key="type">abstract</infon><offset>140</offset><text>Hepatocyte nuclear factor 4alpha (HNF4alpha) is a transcription factor, which is necessary for normal function of human liver and pancreatic islets. We investigated whether single nucleotide polymorphisms (SNPs) of HNF4A, encoding HNF4alpha, influenced the conversion from impaired glucose tolerance (IGT) to type 2 diabetes mellitus in subjects of the STOP-NIDDM trial. This trial aimed at evaluating the effect of acarbose compared to placebo in the prevention of type 2 diabetes mellitus. Eight SNPs covering the intragenic and alternate P2 promoter regions of HNF4A were genotyped in study samples using the TaqMan Allelic Discrimination Assays. Three SNPs in the P2 promoter region (rs4810424, rs1884614, and rs2144908) were in almost complete association (D'>0.97, r (2)>0.95) and, therefore, only rs4810424 was included in further analyses. Female carriers of the less frequent C allele of rs4810424 had a 1.7-fold elevated risk [95% confidence interval (CI) 1.09-2.66; P=0.020] for the conversion to diabetes compared to women with the common genotype after the adjustment for age, treatment group (placebo or acarbose), smoking, weight at baseline, and weight change. No association was found in men. Haplotype analysis based on three SNPs (rs4810424, rs2071197, and rs3818247) representing the linkage disequilibrium blocks in our study population indicated that the conversion to type 2 diabetes mellitus was dependent on the number of risk alleles in different haplotypes in women. Our results suggest that SNPs of HNF4A and their haplotypes predispose to type 2 diabetes mellitus in female subjects of the STOP-NIDDM study population.</text><annotation id="2"><infon key="identifier">3172</infon><infon key="type">GeneOrGeneProduct</infon><location offset="140" length="32"/><text>Hepatocyte nuclear factor 4alpha</text></annotation><annotation id="3"><infon key="identifier">3172</infon><infon key="type">GeneOrGeneProduct</infon><location offset="174" length="9"/><text>HNF4alpha</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="254" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">3172</infon><infon key="type">GeneOrGeneProduct</infon><location offset="355" length="5"/><text>HNF4A</text></annotation><annotation id="6"><infon key="identifier">3172</infon><infon key="type">GeneOrGeneProduct</infon><location offset="371" length="9"/><text>HNF4alpha</text></annotation><annotation id="7"><infon key="identifier">D018149</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="413" length="26"/><text>impaired glucose tolerance</text></annotation><annotation id="8"><infon key="identifier">D018149</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="441" length="3"/><text>IGT</text></annotation><annotation id="9"><infon key="identifier">D003924</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="449" length="24"/><text>type 2 diabetes mellitus</text></annotation><annotation id="10"><infon key="identifier">D020909</infon><infon key="type">ChemicalEntity</infon><location offset="556" length="8"/><text>acarbose</text></annotation><annotation id="11"><infon key="identifier">D003924</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="606" length="24"/><text>type 2 diabetes mellitus</text></annotation><annotation id="12"><infon key="identifier">3172</infon><infon key="type">GeneOrGeneProduct</infon><location offset="704" length="5"/><text>HNF4A</text></annotation><annotation id="13"><infon key="identifier">rs4810424</infon><infon key="type">SequenceVariant</infon><location offset="828" length="9"/><text>rs4810424</text></annotation><annotation id="14"><infon key="identifier">rs1884614</infon><infon key="type">SequenceVariant</infon><location offset="839" length="9"/><text>rs1884614</text></annotation><annotation id="15"><infon key="identifier">rs2144908</infon><infon key="type">SequenceVariant</infon><location offset="854" length="9"/><text>rs2144908</text></annotation><annotation id="16"><infon key="identifier">rs4810424</infon><infon key="type">SequenceVariant</infon><location offset="944" length="9"/><text>rs4810424</text></annotation><annotation id="17"><infon key="identifier">rs4810424</infon><infon key="type">SequenceVariant</infon><location offset="1037" length="9"/><text>rs4810424</text></annotation><annotation id="18"><infon key="identifier">D003920</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1148" length="8"/><text>diabetes</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1169" length="5"/><text>women</text></annotation><annotation id="20"><infon key="identifier">D020909</infon><infon key="type">ChemicalEntity</infon><location offset="1258" length="8"/><text>acarbose</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1345" length="3"/><text>men</text></annotation><annotation id="22"><infon key="identifier">rs4810424</infon><infon key="type">SequenceVariant</infon><location offset="1390" length="9"/><text>rs4810424</text></annotation><annotation id="23"><infon key="identifier">rs2071197</infon><infon key="type">SequenceVariant</infon><location offset="1401" length="9"/><text>rs2071197</text></annotation><annotation id="24"><infon key="identifier">rs3818247</infon><infon key="type">SequenceVariant</infon><location offset="1416" length="9"/><text>rs3818247</text></annotation><annotation id="25"><infon key="identifier">D003924</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1531" length="24"/><text>type 2 diabetes mellitus</text></annotation><annotation id="26"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1627" length="5"/><text>women</text></annotation><annotation id="27"><infon key="identifier">3172</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1667" length="5"/><text>HNF4A</text></annotation><annotation id="28"><infon key="identifier">D003924</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1708" length="24"/><text>type 2 diabetes mellitus</text></annotation></passage><relation id="R0"><infon key="entity1">rs2071197</infon><infon key="entity2">rs3818247</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">rs4810424</infon><infon key="entity2">rs3818247</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">rs4810424</infon><infon key="entity2">rs2071197</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">rs4810424</infon><infon key="entity2">D003920</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">D003920</infon><infon key="entity2">rs2144908</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">D003920</infon><infon key="entity2">rs1884614</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">rs2144908</infon><infon key="entity2">D003924</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">rs1884614</infon><infon key="entity2">D003924</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">D020909</infon><infon key="entity2">D018149</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R9"><infon key="entity1">D020909</infon><infon key="entity2">D003924</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R10"><infon key="entity1">D003924</infon><infon key="entity2">rs3818247</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">D003924</infon><infon key="entity2">rs2071197</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R12"><infon key="entity1">D003924</infon><infon key="entity2">rs4810424</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R13"><infon key="entity1">3172</infon><infon key="entity2">D003924</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>20801540</id><passage><infon key="type">title</infon><offset>0</offset><text>Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.</text><annotation id="0"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="22" length="4"/><text>iron</text></annotation><annotation id="1"><infon key="identifier">D000077588</infon><infon key="type">ChemicalEntity</infon><location offset="50" length="11"/><text>deferasirox</text></annotation><annotation id="2"><infon key="identifier">C536004</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="65" length="18"/><text>aceruloplasminemia</text></annotation></passage><passage><infon key="type">abstract</infon><offset>114</offset><text>BACKGROUND _#38; AIMS: Aceruloplasminemia is a rare autosomal recessive neurodegenerative disease associated with brain and liver iron accumulation which typically presents with movement disorders, retinal degeneration, and diabetes mellitus. Ceruloplasmin is a multi-copper ferroxidase that is secreted into plasma and facilitates cellular iron export and iron binding to transferrin. RESULTS: A novel homozygous ceruloplasmin gene mutation, c.2554+1G>T, was identified as the cause of aceruloplasminemia in three affected siblings. Two siblings presented with movement disorders and diabetes. Complementary DNA sequencing showed that this mutation causes skipping of exon 14 and deletion of amino acids 809-852 while preserving the open reading frame. Western blotting of liver extracts and sera of affected patients showed retention of the abnormal protein in the liver. Aceruloplasminemia was associated with severe brain and liver iron overload, where hepatic mRNA expression of the iron hormone hepcidin was increased, corresponding to the degree of iron overload. Hepatic iron concentration normalized after 3 and 5months of iron chelation therapy with deferasirox, which was also associated with reduced insulin demands. During short term treatment there was no clinical or imaging evidence for significant effects on brain iron overload. CONCLUSIONS: Aceruloplasminemia can show an incomplete clinical penetrance but is invariably associated with iron accumulation in the liver and in the brain. Iron accumulation in aceruloplasminemia is a result of defective cellular iron export, where hepcidin regulation is appropriate for the degree of iron overload. Iron chelation with deferasirox was effective in mobilizing hepatic iron but has no effect on brain iron.</text><annotation id="3"><infon key="identifier">C536004</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="137" length="18"/><text>Aceruloplasminemia</text></annotation><annotation id="4"><infon key="identifier">D020271</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="166" length="45"/><text>autosomal recessive neurodegenerative disease</text></annotation><annotation id="5"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="244" length="4"/><text>iron</text></annotation><annotation id="6"><infon key="identifier">D009069</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="292" length="18"/><text>movement disorders</text></annotation><annotation id="7"><infon key="identifier">D012162</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="312" length="20"/><text>retinal degeneration</text></annotation><annotation id="8"><infon key="identifier">D003920</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="338" length="17"/><text>diabetes mellitus</text></annotation><annotation id="9"><infon key="identifier">1356</infon><infon key="type">GeneOrGeneProduct</infon><location offset="357" length="13"/><text>Ceruloplasmin</text></annotation><annotation id="10"><infon key="identifier">-</infon><infon key="type">ChemicalEntity</infon><location offset="389" length="11"/><text>ferroxidase</text></annotation><annotation id="11"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="455" length="4"/><text>iron</text></annotation><annotation id="12"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="471" length="4"/><text>iron</text></annotation><annotation id="13"><infon key="identifier">7018</infon><infon key="type">GeneOrGeneProduct</infon><location offset="487" length="11"/><text>transferrin</text></annotation><annotation id="14"><infon key="identifier">1356</infon><infon key="type">GeneOrGeneProduct</infon><location offset="528" length="13"/><text>ceruloplasmin</text></annotation><annotation id="15"><infon key="identifier">c|SUB|G|2554+1|T</infon><infon key="type">SequenceVariant</infon><location offset="557" length="11"/><text>c.2554+1G>T</text></annotation><annotation id="16"><infon key="identifier">C536004</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="601" length="18"/><text>aceruloplasminemia</text></annotation><annotation id="17"><infon key="identifier">D009069</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="676" length="18"/><text>movement disorders</text></annotation><annotation id="18"><infon key="identifier">D003920</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="699" length="8"/><text>diabetes</text></annotation><annotation id="19"><infon key="identifier">c|DEL|809_852|</infon><infon key="type">SequenceVariant</infon><location offset="795" length="31"/><text>deletion of amino acids 809-852</text></annotation><annotation id="20"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="924" length="8"/><text>patients</text></annotation><annotation id="21"><infon key="identifier">C536004</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="988" length="18"/><text>Aceruloplasminemia</text></annotation><annotation id="22"><infon key="identifier">D019190</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1050" length="13"/><text>iron overload</text></annotation><annotation id="23"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1102" length="4"/><text>iron</text></annotation><annotation id="24"><infon key="identifier">57817</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1115" length="8"/><text>hepcidin</text></annotation><annotation id="25"><infon key="identifier">D019190</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1170" length="13"/><text>iron overload</text></annotation><annotation id="26"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1193" length="4"/><text>iron</text></annotation><annotation id="27"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1246" length="4"/><text>iron</text></annotation><annotation id="28"><infon key="identifier">D000077588</infon><infon key="type">ChemicalEntity</infon><location offset="1274" length="11"/><text>deferasirox</text></annotation><annotation id="29"><infon key="identifier">3630</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1326" length="7"/><text>insulin</text></annotation><annotation id="30"><infon key="identifier">D019190</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1446" length="13"/><text>iron overload</text></annotation><annotation id="31"><infon key="identifier">C536004</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1474" length="18"/><text>Aceruloplasminemia</text></annotation><annotation id="32"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1570" length="4"/><text>iron</text></annotation><annotation id="33"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1619" length="4"/><text>Iron</text></annotation><annotation id="34"><infon key="identifier">C536004</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1640" length="18"/><text>aceruloplasminemia</text></annotation><annotation id="35"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1693" length="4"/><text>iron</text></annotation><annotation id="36"><infon key="identifier">57817</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1712" length="8"/><text>hepcidin</text></annotation><annotation id="37"><infon key="identifier">D019190</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1765" length="13"/><text>iron overload</text></annotation><annotation id="38"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1780" length="4"/><text>Iron</text></annotation><annotation id="39"><infon key="identifier">D000077588</infon><infon key="type">ChemicalEntity</infon><location offset="1800" length="11"/><text>deferasirox</text></annotation><annotation id="40"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1848" length="4"/><text>iron</text></annotation><annotation id="41"><infon key="identifier">D007501</infon><infon key="type">ChemicalEntity</infon><location offset="1880" length="4"/><text>iron</text></annotation></passage><relation id="R0"><infon key="entity1">57817</infon><infon key="entity2">D019190</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D019190</infon><infon key="entity2">D000077588</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">D019190</infon><infon key="entity2">D007501</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">c|SUB|G|2554+1|T</infon><infon key="entity2">D003920</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">c|SUB|G|2554+1|T</infon><infon key="entity2">D009069</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">c|SUB|G|2554+1|T</infon><infon key="entity2">C536004</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">1356</infon><infon key="entity2">D003920</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">1356</infon><infon key="entity2">D009069</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">1356</infon><infon key="entity2">C536004</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R9"><infon key="entity1">1356</infon><infon key="entity2">D007501</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R10"><infon key="entity1">C536004</infon><infon key="entity2">57817</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">C536004</infon><infon key="entity2">D007501</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R12"><infon key="entity1">D000077588</infon><infon key="entity2">3630</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R13"><infon key="entity1">D000077588</infon><infon key="entity2">C536004</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R14"><infon key="entity1">D007501</infon><infon key="entity2">D012162</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R15"><infon key="entity1">D007501</infon><infon key="entity2">D003920</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R16"><infon key="entity1">D007501</infon><infon key="entity2">D009069</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R17"><infon key="entity1">D007501</infon><infon key="entity2">7018</infon><infon key="type">Bind</infon><infon key="novel">No</infon></relation><relation id="R18"><infon key="entity1">D007501</infon><infon key="entity2">D000077588</infon><infon key="type">Bind</infon><infon key="novel">Novel</infon></relation></document><document><id>25550469</id><passage><infon key="type">title</infon><offset>0</offset><text>The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice.</text><annotation id="0"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="4" length="17"/><text>androgen receptor</text></annotation><annotation id="1"><infon key="identifier">D050197</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="62" length="15"/><text>atherosclerosis</text></annotation><annotation id="2"><infon key="identifier">D009765</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="79" length="7"/><text>obesity</text></annotation><annotation id="3"><infon key="identifier">D050171</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="92" length="12"/><text>dyslipidemia</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="115" length="4"/><text>mice</text></annotation></passage><passage><infon key="type">abstract</infon><offset>121</offset><text>Androgens have important cardiometabolic actions in males, but their metabolic role in females is unclear. To determine the physiologic androgen receptor (AR)-dependent actions of androgens on atherogenesis in female mice, we generated female AR-knockout (ARKO) mice on an atherosclerosis-prone apolipoprotein E (apoE)-deficient background. After 8 weeks on a high-fat diet, but not on a normal chow diet, atherosclerosis in aorta was increased in ARKO females (+59% vs. control apoE-deficient mice with intact AR gene). They also displayed increased body weight (+18%), body fat percentage (+62%), and hepatic triglyceride levels, reduced insulin sensitivity, and a marked atherogenic dyslipidemia (serum cholesterol, +52%). Differences in atherosclerosis, body weight, and lipid levels between ARKO and control mice were abolished in mice that were ovariectomized before puberty, consistent with a protective action of ovarian androgens mediated via the AR. Furthermore, the AR agonist dihydrotestosterone reduced atherosclerosis (-41%; thoracic aorta), subcutaneous fat mass (-44%), and cholesterol levels (-35%) in ovariectomized mice, reduced hepatocyte lipid accumulation in hepatoma cells in vitro, and regulated mRNA expression of hepatic genes pivotal for lipid homeostasis. In conclusion, we demonstrate that the AR protects against diet-induced atherosclerosis in female mice and propose that this is mediated by modulation of body composition and lipid metabolism.</text><annotation id="5"><infon key="identifier">D000728</infon><infon key="type">ChemicalEntity</infon><location offset="121" length="9"/><text>Androgens</text></annotation><annotation id="6"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="257" length="17"/><text>androgen receptor</text></annotation><annotation id="7"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="276" length="2"/><text>AR</text></annotation><annotation id="8"><infon key="identifier">D000728</infon><infon key="type">ChemicalEntity</infon><location offset="301" length="9"/><text>androgens</text></annotation><annotation id="9"><infon key="identifier">D050197</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="314" length="13"/><text>atherogenesis</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="338" length="4"/><text>mice</text></annotation><annotation id="11"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="364" length="2"/><text>AR</text></annotation><annotation id="12"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="377" length="2"/><text>AR</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="383" length="4"/><text>mice</text></annotation><annotation id="14"><infon key="identifier">D050197</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="394" length="15"/><text>atherosclerosis</text></annotation><annotation id="15"><infon key="identifier">11816</infon><infon key="type">GeneOrGeneProduct</infon><location offset="416" length="16"/><text>apolipoprotein E</text></annotation><annotation id="16"><infon key="identifier">11816</infon><infon key="type">GeneOrGeneProduct</infon><location offset="434" length="4"/><text>apoE</text></annotation><annotation id="17"><infon key="identifier">D050197</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="527" length="15"/><text>atherosclerosis</text></annotation><annotation id="18"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="569" length="2"/><text>AR</text></annotation><annotation id="19"><infon key="identifier">11816</infon><infon key="type">GeneOrGeneProduct</infon><location offset="600" length="4"/><text>apoE</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="615" length="4"/><text>mice</text></annotation><annotation id="21"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="632" length="2"/><text>AR</text></annotation><annotation id="22"><infon key="identifier">100035834</infon><infon key="type">GeneOrGeneProduct</infon><location offset="732" length="12"/><text>triglyceride</text></annotation><annotation id="23"><infon key="identifier">16334</infon><infon key="type">GeneOrGeneProduct</infon><location offset="761" length="7"/><text>insulin</text></annotation><annotation id="24"><infon key="identifier">D050197</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="795" length="11"/><text>atherogenic</text></annotation><annotation id="25"><infon key="identifier">D050171</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="807" length="12"/><text>dyslipidemia</text></annotation><annotation id="26"><infon key="identifier">D002784</infon><infon key="type">ChemicalEntity</infon><location offset="827" length="11"/><text>cholesterol</text></annotation><annotation id="27"><infon key="identifier">D050197</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="862" length="15"/><text>atherosclerosis</text></annotation><annotation id="28"><infon key="identifier">D008055</infon><infon key="type">ChemicalEntity</infon><location offset="896" length="5"/><text>lipid</text></annotation><annotation id="29"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="917" length="2"/><text>AR</text></annotation><annotation id="30"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="934" length="4"/><text>mice</text></annotation><annotation id="31"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="957" length="4"/><text>mice</text></annotation><annotation id="32"><infon key="identifier">D000728</infon><infon key="type">ChemicalEntity</infon><location offset="1050" length="9"/><text>androgens</text></annotation><annotation id="33"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1077" length="2"/><text>AR</text></annotation><annotation id="34"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1098" length="2"/><text>AR</text></annotation><annotation id="35"><infon key="identifier">D013196</infon><infon key="type">ChemicalEntity</infon><location offset="1109" length="19"/><text>dihydrotestosterone</text></annotation><annotation id="36"><infon key="identifier">D050197</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1137" length="15"/><text>atherosclerosis</text></annotation><annotation id="37"><infon key="identifier">D002784</infon><infon key="type">ChemicalEntity</infon><location offset="1211" length="11"/><text>cholesterol</text></annotation><annotation id="38"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="1255" length="4"/><text>mice</text></annotation><annotation id="39"><infon key="identifier">D008055</infon><infon key="type">ChemicalEntity</infon><location offset="1280" length="5"/><text>lipid</text></annotation><annotation id="40"><infon key="identifier">D006528</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1302" length="8"/><text>hepatoma</text></annotation><annotation id="41"><infon key="identifier">D008055</infon><infon key="type">ChemicalEntity</infon><location offset="1386" length="5"/><text>lipid</text></annotation><annotation id="42"><infon key="identifier">11835</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1444" length="2"/><text>AR</text></annotation><annotation id="43"><infon key="identifier">D050197</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1477" length="15"/><text>atherosclerosis</text></annotation><annotation id="44"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="1503" length="4"/><text>mice</text></annotation><annotation id="45"><infon key="identifier">D008055</infon><infon key="type">ChemicalEntity</infon><location offset="1580" length="5"/><text>lipid</text></annotation></passage><relation id="R0"><infon key="entity1">D013196</infon><infon key="entity2">D008055</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D013196</infon><infon key="entity2">D002784</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">D013196</infon><infon key="entity2">D050197</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">D050197</infon><infon key="entity2">D008055</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">D050197</infon><infon key="entity2">D002784</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R5"><infon key="entity1">D050171</infon><infon key="entity2">D002784</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R6"><infon key="entity1">D050171</infon><infon key="entity2">11835</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">100035834</infon><infon key="entity2">11835</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R8"><infon key="entity1">11835</infon><infon key="entity2">D013196</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R9"><infon key="entity1">11835</infon><infon key="entity2">D000728</infon><infon key="type">Bind</infon><infon key="novel">No</infon></relation><relation id="R10"><infon key="entity1">11835</infon><infon key="entity2">D050197</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R11"><infon key="entity1">11835</infon><infon key="entity2">16334</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R12"><infon key="entity1">11835</infon><infon key="entity2">D009765</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>27090298</id><passage><infon key="type">title</infon><offset>0</offset><text>Circulating Fatty Acid Synthase in pregnant women: Relationship to blood pressure, maternal metabolism and newborn parameters.</text><annotation id="0"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="12" length="19"/><text>Fatty Acid Synthase</text></annotation><annotation id="1"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="44" length="5"/><text>women</text></annotation></passage><passage><infon key="type">abstract</infon><offset>127</offset><text>The enzyme FASN (fatty acid synthase) is potentially related with hypertension and metabolic dysfunction. FASN is highly expressed in the human placenta. We aimed to investigate the relationship circulating FASN has with blood pressure, maternal metabolism and newborn parameters in healthy pregnant women. Circulating FASN was assessed in 115 asymptomatic pregnant women in the second trimester of gestation along with C-peptide, fasting glucose and insulin, post-load glucose lipids, HMW-adiponectin and blood pressure (the latter was assessed in each trimester of gestation). At birth, newborns and placentas were weighed. FASN expression was also able to be assessed in 80 placentas. Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p &lt; 0.05 to p &lt; 0.001). Placental FASN expression related positively to circulating FASN (p &lt; 0.005) and negatively to placental weight (p &lt; 0.05). Our observations suggest a physiological role of placental FASN in human pregnancy. Future studies will clarify whether circulating FASN of placental origin does actually regulate placental and fetal growth, and (thereby) has a favourable influence on the pregnant mother's insulin sensitivity and blood pressure.</text><annotation id="2"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="138" length="4"/><text>FASN</text></annotation><annotation id="3"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="144" length="19"/><text>fatty acid synthase</text></annotation><annotation id="4"><infon key="identifier">D006973</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="193" length="12"/><text>hypertension</text></annotation><annotation id="5"><infon key="identifier">D008659</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="210" length="21"/><text>metabolic dysfunction</text></annotation><annotation id="6"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="233" length="4"/><text>FASN</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="265" length="5"/><text>human</text></annotation><annotation id="8"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="334" length="4"/><text>FASN</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="427" length="5"/><text>women</text></annotation><annotation id="10"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="446" length="4"/><text>FASN</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="493" length="5"/><text>women</text></annotation><annotation id="12"><infon key="identifier">D002096</infon><infon key="type">ChemicalEntity</infon><location offset="547" length="9"/><text>C-peptide</text></annotation><annotation id="13"><infon key="identifier">D005947</infon><infon key="type">ChemicalEntity</infon><location offset="566" length="7"/><text>glucose</text></annotation><annotation id="14"><infon key="identifier">3630</infon><infon key="type">GeneOrGeneProduct</infon><location offset="578" length="7"/><text>insulin</text></annotation><annotation id="15"><infon key="identifier">D005947</infon><infon key="type">ChemicalEntity</infon><location offset="597" length="7"/><text>glucose</text></annotation><annotation id="16"><infon key="identifier">D008055</infon><infon key="type">ChemicalEntity</infon><location offset="605" length="6"/><text>lipids</text></annotation><annotation id="17"><infon key="identifier">57587</infon><infon key="type">GeneOrGeneProduct</infon><location offset="613" length="3"/><text>HMW</text></annotation><annotation id="18"><infon key="identifier">9370</infon><infon key="type">GeneOrGeneProduct</infon><location offset="617" length="11"/><text>adiponectin</text></annotation><annotation id="19"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="753" length="4"/><text>FASN</text></annotation><annotation id="20"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="834" length="4"/><text>FASN</text></annotation><annotation id="21"><infon key="identifier">D005947</infon><infon key="type">ChemicalEntity</infon><location offset="954" length="7"/><text>glucose</text></annotation><annotation id="22"><infon key="identifier">3630</infon><infon key="type">GeneOrGeneProduct</infon><location offset="966" length="7"/><text>insulin</text></annotation><annotation id="23"><infon key="identifier">D005947</infon><infon key="type">ChemicalEntity</infon><location offset="985" length="7"/><text>glucose</text></annotation><annotation id="24"><infon key="identifier">3043</infon><infon key="type">GeneOrGeneProduct</infon><location offset="994" length="5"/><text>HbAc1</text></annotation><annotation id="25"><infon key="identifier">D002096</infon><infon key="type">ChemicalEntity</infon><location offset="1013" length="9"/><text>C-peptide</text></annotation><annotation id="26"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1106" length="4"/><text>FASN</text></annotation><annotation id="27"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1156" length="4"/><text>FASN</text></annotation><annotation id="28"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1279" length="4"/><text>FASN</text></annotation><annotation id="29"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1287" length="5"/><text>human</text></annotation><annotation id="30"><infon key="identifier">2194</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1352" length="4"/><text>FASN</text></annotation><annotation id="31"><infon key="identifier">3630</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1494" length="7"/><text>insulin</text></annotation></passage><relation id="R0"><infon key="entity1">2194</infon><infon key="entity2">D008659</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">2194</infon><infon key="entity2">D006973</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">2194</infon><infon key="entity2">D002096</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">2194</infon><infon key="entity2">3043</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">2194</infon><infon key="entity2">3630</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">2194</infon><infon key="entity2">D005947</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">57587</infon><infon key="entity2">9370</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation></document><document><id>27860185</id><passage><infon key="type">title</infon><offset>0</offset><text>Sildenafil attenuates hypoxic pulmonary remodelling by inhibiting bone marrow progenitor cells.</text><annotation id="0"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="0" length="10"/><text>Sildenafil</text></annotation><annotation id="1"><infon key="identifier">D066253</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="22" length="29"/><text>hypoxic pulmonary remodelling</text></annotation></passage><passage><infon key="type">abstract</infon><offset>96</offset><text>The recruitment of bone marrow (BM)-derived progenitor cells to the lung is related to pulmonary remodelling and the pathogenesis of pulmonary hypertension (PH). Although sildenafil is a known target in PH treatment, the underlying molecular mechanism is still elusive. To test the hypothesis that the therapeutic effect of sildenafil is linked to the reduced recruitment of BM-derived progenitor cells, we induced pulmonary remodelling in rats by two-week exposure to chronic hypoxia (CH, 10% oxygen), a trigger of BM-derived progenitor cells. Rats were treated with either placebo (saline) or sildenafil (1.4 mg/kg/day ip) during CH. Control rats were kept in room air (21% oxygen) with no treatment. As expected, sildenafil attenuated the CH-induced increase in right ventricular systolic pressure and right ventricular hypertrophy. However, sildenafil suppressed the CH-induced increase in c-kit(+) cells in the adventitia of pulmonary arteries. Moreover, sildenafil reduced the number of c-kit(+) cells that colocalize with tyrosine kinase receptor 2 (VEGF-R2) and CD68 (a marker for macrophages), indicating a positive effect on moderating hypoxia-induced smooth muscle cell proliferation and inflammation without affecting the pulmonary levels of hypoxia-inducible factor (HIF)-1a. Furthermore, sildenafil depressed the number of CXCR4(+) cells. Collectively, these findings indicate that the improvement in pulmonary haemodynamic by sildenafil is linked to decreased recruitment of BM-derived c-kit(+) cells in the pulmonary tissue. The attenuation of the recruitment of BM-derived c-kit(+) cells by sildenafil may provide novel therapeutic insights into the control of pulmonary remodelling.</text><annotation id="2"><infon key="identifier">D066253</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="183" length="21"/><text>pulmonary remodelling</text></annotation><annotation id="3"><infon key="identifier">D006976</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="229" length="22"/><text>pulmonary hypertension</text></annotation><annotation id="4"><infon key="identifier">D006976</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="253" length="2"/><text>PH</text></annotation><annotation id="5"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="267" length="10"/><text>sildenafil</text></annotation><annotation id="6"><infon key="identifier">D006976</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="299" length="2"/><text>PH</text></annotation><annotation id="7"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="420" length="10"/><text>sildenafil</text></annotation><annotation id="8"><infon key="identifier">D066253</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="511" length="21"/><text>pulmonary remodelling</text></annotation><annotation id="9"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="536" length="4"/><text>rats</text></annotation><annotation id="10"><infon key="identifier">D000860</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="573" length="7"/><text>hypoxia</text></annotation><annotation id="11"><infon key="identifier">D000860</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="582" length="2"/><text>CH</text></annotation><annotation id="12"><infon key="identifier">D010100</infon><infon key="type">ChemicalEntity</infon><location offset="590" length="6"/><text>oxygen</text></annotation><annotation id="13"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="641" length="4"/><text>Rats</text></annotation><annotation id="14"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="691" length="10"/><text>sildenafil</text></annotation><annotation id="15"><infon key="identifier">D000860</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="728" length="2"/><text>CH</text></annotation><annotation id="16"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="740" length="4"/><text>rats</text></annotation><annotation id="17"><infon key="identifier">D010100</infon><infon key="type">ChemicalEntity</infon><location offset="772" length="6"/><text>oxygen</text></annotation><annotation id="18"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="812" length="10"/><text>sildenafil</text></annotation><annotation id="19"><infon key="identifier">D000860</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="838" length="2"/><text>CH</text></annotation><annotation id="20"><infon key="identifier">D017380</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="901" length="29"/><text>right ventricular hypertrophy</text></annotation><annotation id="21"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="941" length="10"/><text>sildenafil</text></annotation><annotation id="22"><infon key="identifier">D000860</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="967" length="2"/><text>CH</text></annotation><annotation id="23"><infon key="identifier">64030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="990" length="5"/><text>c-kit</text></annotation><annotation id="24"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="1056" length="10"/><text>sildenafil</text></annotation><annotation id="25"><infon key="identifier">64030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1089" length="5"/><text>c-kit</text></annotation><annotation id="26"><infon key="identifier">25589</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1125" length="26"/><text>tyrosine kinase receptor 2</text></annotation><annotation id="27"><infon key="identifier">25589</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1153" length="7"/><text>VEGF-R2</text></annotation><annotation id="28"><infon key="identifier">287435</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1166" length="4"/><text>CD68</text></annotation><annotation id="29"><infon key="identifier">D000860</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1242" length="7"/><text>hypoxia</text></annotation><annotation id="30"><infon key="identifier">D007249</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1295" length="12"/><text>inflammation</text></annotation><annotation id="31"><infon key="identifier">29560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1350" length="33"/><text>hypoxia-inducible factor (HIF)-1a</text></annotation><annotation id="32"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="1398" length="10"/><text>sildenafil</text></annotation><annotation id="33"><infon key="identifier">60628</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1433" length="5"/><text>CXCR4</text></annotation><annotation id="34"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="1537" length="10"/><text>sildenafil</text></annotation><annotation id="35"><infon key="identifier">64030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1597" length="5"/><text>c-kit</text></annotation><annotation id="36"><infon key="identifier">64030</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1686" length="5"/><text>c-kit</text></annotation><annotation id="37"><infon key="identifier">D000068677</infon><infon key="type">ChemicalEntity</infon><location offset="1704" length="10"/><text>sildenafil</text></annotation><annotation id="38"><infon key="identifier">D066253</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1774" length="21"/><text>pulmonary remodelling</text></annotation></passage><relation id="R0"><infon key="entity1">D000068677</infon><infon key="entity2">D006976</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">D000068677</infon><infon key="entity2">D066253</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">D000068677</infon><infon key="entity2">60628</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">D000068677</infon><infon key="entity2">D007249</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">D000068677</infon><infon key="entity2">287435</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R5"><infon key="entity1">D000068677</infon><infon key="entity2">25589</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R6"><infon key="entity1">D000068677</infon><infon key="entity2">D017380</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R7"><infon key="entity1">D000068677</infon><infon key="entity2">D000860</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>15867855</id><passage><infon key="type">title</infon><offset>0</offset><text>Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population.</text><annotation id="0"><infon key="identifier">26762</infon><infon key="type">GeneOrGeneProduct</infon><location offset="24" length="29"/><text>T-cell immunoglobulin mucin 1</text></annotation><annotation id="1"><infon key="identifier">84868</infon><infon key="type">GeneOrGeneProduct</infon><location offset="66" length="29"/><text>T-cell immunoglobulin mucin 3</text></annotation><annotation id="2"><infon key="identifier">D001249</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="121" length="6"/><text>asthma</text></annotation></passage><passage><infon key="type">abstract</infon><offset>163</offset><text>BACKGROUND: The T-cell immunoglobulin mucin ( TIM ) proteins and their genetic variants have been suggested to play a role in regulating allergic diseases. OBJECTIVE: Genetic association of the sequence variants for TIM-1 and TIM-3 genes with asthma in an African American population was investigated. METHODS: Both case-control and family-based association analyses were performed for a total of 7 polymorphisms, including 3 single nucleotide polymorphism (SNPs) and 1 insertion/deletion polymorphism in the TIM-1 and 3 SNPs in the TIM-3 genes. The exposure to hepatitis A virus as judged by seropositivity was also examined. RESULTS: In the case-control design, the frequencies of the TT genotype for SNP rs2277025 and the homozygous deletion variant (157delMTTTVP) in the fourth exon of the TIM-1 gene were higher among patients with patients with asthma compared with the controls (odds ratio [OR], 2.779, P = .016; and OR, 3.09, P = .022, respectively). This association was substantiated by haplotype analysis of these and 2 additional SNPs (OR, 2.48; P = .004), and also by family-based tests for the allele and haplotype carrying 157delMTTTVP (P = .009 and P = .048, respectively). Furthermore, this association seems to exist even in the hepatitis A virus-seronegative subjects in our data. None of the 3 variants in TIM-3 genes yielded significant association with either asthma or asthma-related phenotypes. CONCLUSION: Our findings suggest that the genetic variants of the TIM-1 but not the TIM-3 gene contribute to asthma susceptibility in this African-American population.</text><annotation id="3"><infon key="identifier">26762,84868</infon><infon key="type">GeneOrGeneProduct</infon><location offset="179" length="27"/><text>T-cell immunoglobulin mucin</text></annotation><annotation id="4"><infon key="identifier">26762,84868</infon><infon key="type">GeneOrGeneProduct</infon><location offset="209" length="3"/><text>TIM</text></annotation><annotation id="5"><infon key="identifier">D004342</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="300" length="17"/><text>allergic diseases</text></annotation><annotation id="6"><infon key="identifier">26762</infon><infon key="type">GeneOrGeneProduct</infon><location offset="379" length="5"/><text>TIM-1</text></annotation><annotation id="7"><infon key="identifier">84868</infon><infon key="type">GeneOrGeneProduct</infon><location offset="389" length="5"/><text>TIM-3</text></annotation><annotation id="8"><infon key="identifier">D001249</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="406" length="6"/><text>asthma</text></annotation><annotation id="9"><infon key="identifier">26762,84868</infon><infon key="type">GeneOrGeneProduct</infon><location offset="672" length="11"/><text>TIM-1 and 3</text></annotation><annotation id="10"><infon key="identifier">84868</infon><infon key="type">GeneOrGeneProduct</infon><location offset="696" length="5"/><text>TIM-3</text></annotation><annotation id="11"><infon key="identifier">208726</infon><infon key="type">OrganismTaxon</infon><location offset="725" length="17"/><text>hepatitis A virus</text></annotation><annotation id="12"><infon key="identifier">rs2277025</infon><infon key="type">SequenceVariant</infon><location offset="870" length="9"/><text>rs2277025</text></annotation><annotation id="13"><infon key="identifier">p|DEL|157|MTTTVP</infon><infon key="type">SequenceVariant</infon><location offset="917" length="12"/><text>157delMTTTVP</text></annotation><annotation id="14"><infon key="identifier">26762</infon><infon key="type">GeneOrGeneProduct</infon><location offset="957" length="5"/><text>TIM-1</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="986" length="8"/><text>patients</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1000" length="8"/><text>patients</text></annotation><annotation id="17"><infon key="identifier">D001249</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1014" length="6"/><text>asthma</text></annotation><annotation id="18"><infon key="identifier">p|DEL|157|MTTTVP</infon><infon key="type">SequenceVariant</infon><location offset="1301" length="12"/><text>157delMTTTVP</text></annotation><annotation id="19"><infon key="identifier">208726</infon><infon key="type">OrganismTaxon</infon><location offset="1410" length="17"/><text>hepatitis A virus</text></annotation><annotation id="20"><infon key="identifier">84868</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1489" length="5"/><text>TIM-3</text></annotation><annotation id="21"><infon key="identifier">D001249</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1545" length="6"/><text>asthma</text></annotation><annotation id="22"><infon key="identifier">D001249</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1555" length="6"/><text>asthma</text></annotation><annotation id="23"><infon key="identifier">26762</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1648" length="5"/><text>TIM-1</text></annotation><annotation id="24"><infon key="identifier">84868</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1666" length="5"/><text>TIM-3</text></annotation><annotation id="25"><infon key="identifier">D001249</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1691" length="6"/><text>asthma</text></annotation></passage><relation id="R0"><infon key="entity1">84868</infon><infon key="entity2">D004342</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">p|DEL|157|MTTTVP</infon><infon key="entity2">D001249</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R2"><infon key="entity1">rs2277025</infon><infon key="entity2">D001249</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">26762</infon><infon key="entity2">D004342</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R4"><infon key="entity1">26762</infon><infon key="entity2">D001249</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>26684240</id><passage><infon key="type">title</infon><offset>0</offset><text>Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.</text><annotation id="0"><infon key="identifier">673</infon><infon key="type">GeneOrGeneProduct</infon><location offset="22" length="4"/><text>BRAF</text></annotation><annotation id="1"><infon key="identifier">rs113488022</infon><infon key="type">SequenceVariant</infon><location offset="27" length="5"/><text>V600E</text></annotation><annotation id="2"><infon key="identifier">C535650</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="45" length="44"/><text>gastroenteropancreatic neuroendocrine tumors</text></annotation></passage><passage><infon key="type">abstract</infon><offset>91</offset><text>Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied. Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50). The mean numbers of somatic mutations in each case varied widely from 20 to 4682. Among 12 GEP-NETs, eight showed mutations of more than one cancer-related gene, including TP53, CNBD1, RB1, APC, BCOR, BRAF, CTNNB1, EGFR, EP300, ERBB3, KDM6A, KRAS, MGA, MLL3, PTEN, RASA1, SMARCB1, SPEN, TBC1D12, and VHL. TP53 was recurrently mutated in three cases, whereas CNBD1 and RB1 mutations were identified in two cases. Three GEP-NET patients with TP53 mutations demonstrated a durable response and one small intestinal grade (G) 1 NET patient with BRAF V600E mutation showed progression after pazopanib treatment. We found BRAF V600E (G1 NET from rectum and two G3 NETs from colon) and BRAF G593S (G2 NET from pancreas) missense mutations (9.1%) in an independent cohort of 44 GEP-NETs from the rectum (n = 26), colon (n = 7), pancreas (n = 4), small intestine (n = 3), stomach (n = 3) and appendix (n = 1) by Sanger sequencing. All tumor specimens were obtained before chemotherapy. In conclusion, BRAF V600E mutation is likely to result in resistance to pazopanib but may be a potentianally actionable mutation in metastatic GEP-NETs patients.</text><annotation id="3"><infon key="identifier">C535650</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="111" length="44"/><text>gastroenteropancreatic neuroendocrine tumors</text></annotation><annotation id="4"><infon key="identifier">C535650</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="157" length="8"/><text>GEP-NETs</text></annotation><annotation id="5"><infon key="identifier">C535650</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="334" length="8"/><text>GEP-NETs</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="348" length="8"/><text>patients</text></annotation><annotation id="7"><infon key="identifier">C516667</infon><infon key="type">ChemicalEntity</infon><location offset="433" length="9"/><text>pazopanib</text></annotation><annotation id="8"><infon key="identifier">D007414</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="536" length="14"/><text>intestine NETs</text></annotation><annotation id="9"><infon key="identifier">C535650</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="652" length="8"/><text>GEP-NETs</text></annotation><annotation id="10"><infon key="identifier">D009369</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="702" length="6"/><text>cancer</text></annotation><annotation id="11"><infon key="identifier">7157</infon><infon key="type">GeneOrGeneProduct</infon><location offset="733" length="4"/><text>TP53</text></annotation><annotation id="12"><infon key="identifier">168975</infon><infon key="type">GeneOrGeneProduct</infon><location offset="739" length="5"/><text>CNBD1</text></annotation><annotation id="13"><infon key="identifier">5925</infon><infon key="type">GeneOrGeneProduct</infon><location offset="746" length="3"/><text>RB1</text></annotation><annotation id="14"><infon key="identifier">324</infon><infon key="type">GeneOrGeneProduct</infon><location offset="751" length="3"/><text>APC</text></annotation><annotation id="15"><infon key="identifier">54880</infon><infon key="type">GeneOrGeneProduct</infon><location offset="756" length="4"/><text>BCOR</text></annotation><annotation id="16"><infon key="identifier">673</infon><infon key="type">GeneOrGeneProduct</infon><location offset="762" length="4"/><text>BRAF</text></annotation><annotation id="17"><infon key="identifier">1499</infon><infon key="type">GeneOrGeneProduct</infon><location offset="768" length="6"/><text>CTNNB1</text></annotation><annotation id="18"><infon key="identifier">1956</infon><infon key="type">GeneOrGeneProduct</infon><location offset="776" length="4"/><text>EGFR</text></annotation><annotation id="19"><infon key="identifier">2033</infon><infon key="type">GeneOrGeneProduct</infon><location offset="782" length="5"/><text>EP300</text></annotation><annotation id="20"><infon key="identifier">2065</infon><infon key="type">GeneOrGeneProduct</infon><location offset="789" length="5"/><text>ERBB3</text></annotation><annotation id="21"><infon key="identifier">7403</infon><infon key="type">GeneOrGeneProduct</infon><location offset="796" length="5"/><text>KDM6A</text></annotation><annotation id="22"><infon key="identifier">3845</infon><infon key="type">GeneOrGeneProduct</infon><location offset="803" length="4"/><text>KRAS</text></annotation><annotation id="23"><infon key="identifier">23269</infon><infon key="type">GeneOrGeneProduct</infon><location offset="809" length="3"/><text>MGA</text></annotation><annotation id="24"><infon key="identifier">58508</infon><infon key="type">GeneOrGeneProduct</infon><location offset="814" length="4"/><text>MLL3</text></annotation><annotation id="25"><infon key="identifier">5728</infon><infon key="type">GeneOrGeneProduct</infon><location offset="820" length="4"/><text>PTEN</text></annotation><annotation id="26"><infon key="identifier">5921</infon><infon key="type">GeneOrGeneProduct</infon><location offset="826" length="5"/><text>RASA1</text></annotation><annotation id="27"><infon key="identifier">6598</infon><infon key="type">GeneOrGeneProduct</infon><location offset="833" length="7"/><text>SMARCB1</text></annotation><annotation id="28"><infon key="identifier">23013</infon><infon key="type">GeneOrGeneProduct</infon><location offset="842" length="4"/><text>SPEN</text></annotation><annotation id="29"><infon key="identifier">23232</infon><infon key="type">GeneOrGeneProduct</infon><location offset="848" length="7"/><text>TBC1D12</text></annotation><annotation id="30"><infon key="identifier">7428</infon><infon key="type">GeneOrGeneProduct</infon><location offset="861" length="3"/><text>VHL</text></annotation><annotation id="31"><infon key="identifier">7157</infon><infon key="type">GeneOrGeneProduct</infon><location offset="866" length="4"/><text>TP53</text></annotation><annotation id="32"><infon key="identifier">168975</infon><infon key="type">GeneOrGeneProduct</infon><location offset="919" length="5"/><text>CNBD1</text></annotation><annotation id="33"><infon key="identifier">5925</infon><infon key="type">GeneOrGeneProduct</infon><location offset="929" length="3"/><text>RB1</text></annotation><annotation id="34"><infon key="identifier">C535650</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="979" length="7"/><text>GEP-NET</text></annotation><annotation id="35"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="987" length="8"/><text>patients</text></annotation><annotation id="36"><infon key="identifier">7157</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1001" length="4"/><text>TP53</text></annotation><annotation id="37"><infon key="identifier">D007414</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1062" length="26"/><text>intestinal grade (G) 1 NET</text></annotation><annotation id="38"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1089" length="7"/><text>patient</text></annotation><annotation id="39"><infon key="identifier">673</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1102" length="4"/><text>BRAF</text></annotation><annotation id="40"><infon key="identifier">rs113488022</infon><infon key="type">SequenceVariant</infon><location offset="1107" length="5"/><text>V600E</text></annotation><annotation id="41"><infon key="identifier">C516667</infon><infon key="type">ChemicalEntity</infon><location offset="1147" length="9"/><text>pazopanib</text></annotation><annotation id="42"><infon key="identifier">673</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1177" length="4"/><text>BRAF</text></annotation><annotation id="43"><infon key="identifier">rs113488022</infon><infon key="type">SequenceVariant</infon><location offset="1182" length="5"/><text>V600E</text></annotation><annotation id="44"><infon key="identifier">D018358</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1192" length="3"/><text>NET</text></annotation><annotation id="45"><infon key="identifier">D018358</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1219" length="4"/><text>NETs</text></annotation><annotation id="46"><infon key="identifier">673</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1240" length="4"/><text>BRAF</text></annotation><annotation id="47"><infon key="identifier">p.G593S</infon><infon key="type">SequenceVariant</infon><location offset="1245" length="5"/><text>G593S</text></annotation><annotation id="48"><infon key="identifier">D018358</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1255" length="3"/><text>NET</text></annotation><annotation id="49"><infon key="identifier">C535650</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1331" length="8"/><text>GEP-NETs</text></annotation><annotation id="50"><infon key="identifier">D009369</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1487" length="5"/><text>tumor</text></annotation><annotation id="51"><infon key="identifier">673</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1553" length="4"/><text>BRAF</text></annotation><annotation id="52"><infon key="identifier">rs113488022</infon><infon key="type">SequenceVariant</infon><location offset="1558" length="5"/><text>V600E</text></annotation><annotation id="53"><infon key="identifier">C516667</infon><infon key="type">ChemicalEntity</infon><location offset="1610" length="9"/><text>pazopanib</text></annotation><annotation id="54"><infon key="identifier">C535650</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1681" length="8"/><text>GEP-NETs</text></annotation><annotation id="55"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1690" length="8"/><text>patients</text></annotation></passage><relation id="R0"><infon key="entity1">p.G593S</infon><infon key="entity2">D018358</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">D007414</infon><infon key="entity2">C516667</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">D007414</infon><infon key="entity2">rs113488022</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R3"><infon key="entity1">D007414</infon><infon key="entity2">673</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">7428</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R5"><infon key="entity1">23232</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R6"><infon key="entity1">23013</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R7"><infon key="entity1">6598</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R8"><infon key="entity1">5921</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R9"><infon key="entity1">5728</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R10"><infon key="entity1">58508</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R11"><infon key="entity1">23269</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R12"><infon key="entity1">3845</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R13"><infon key="entity1">7403</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R14"><infon key="entity1">2033</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R15"><infon key="entity1">1956</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R16"><infon key="entity1">1499</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R17"><infon key="entity1">54880</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R18"><infon key="entity1">324</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R19"><infon key="entity1">5925</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R20"><infon key="entity1">168975</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R21"><infon key="entity1">D009369</infon><infon key="entity2">2065</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R22"><infon key="entity1">7157</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R23"><infon key="entity1">rs113488022</infon><infon key="entity2">D018358</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R24"><infon key="entity1">rs113488022</infon><infon key="entity2">C516667</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R25"><infon key="entity1">rs113488022</infon><infon key="entity2">C535650</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R26"><infon key="entity1">C535650</infon><infon key="entity2">p.G593S</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R27"><infon key="entity1">C535650</infon><infon key="entity2">C516667</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R28"><infon key="entity1">C535650</infon><infon key="entity2">7428</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R29"><infon key="entity1">C535650</infon><infon key="entity2">23232</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R30"><infon key="entity1">C535650</infon><infon key="entity2">23013</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R31"><infon key="entity1">C535650</infon><infon key="entity2">6598</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R32"><infon key="entity1">C535650</infon><infon key="entity2">5921</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R33"><infon key="entity1">C535650</infon><infon key="entity2">5728</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R34"><infon key="entity1">C535650</infon><infon key="entity2">58508</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R35"><infon key="entity1">C535650</infon><infon key="entity2">23269</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R36"><infon key="entity1">C535650</infon><infon key="entity2">3845</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R37"><infon key="entity1">C535650</infon><infon key="entity2">7403</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R38"><infon key="entity1">C535650</infon><infon key="entity2">2065</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R39"><infon key="entity1">C535650</infon><infon key="entity2">2033</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R40"><infon key="entity1">C535650</infon><infon key="entity2">1956</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R41"><infon key="entity1">C535650</infon><infon key="entity2">1499</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R42"><infon key="entity1">C535650</infon><infon key="entity2">54880</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R43"><infon key="entity1">C535650</infon><infon key="entity2">324</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R44"><infon key="entity1">C535650</infon><infon key="entity2">5925</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R45"><infon key="entity1">C535650</infon><infon key="entity2">168975</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R46"><infon key="entity1">C535650</infon><infon key="entity2">7157</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R47"><infon key="entity1">673</infon><infon key="entity2">D018358</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation><relation id="R48"><infon key="entity1">673</infon><infon key="entity2">C516667</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R49"><infon key="entity1">673</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R50"><infon key="entity1">673</infon><infon key="entity2">C535650</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>27707793</id><passage><infon key="type">title</infon><offset>0</offset><text>MicroRNA deep sequencing in two adult stem cell populations identifies miR-501 as a novel regulator of myosin heavy chain during muscle regeneration.</text><annotation id="0"><infon key="identifier">751560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="71" length="7"/><text>miR-501</text></annotation><annotation id="1"><infon key="identifier">17883</infon><infon key="type">GeneOrGeneProduct</infon><location offset="103" length="18"/><text>myosin heavy chain</text></annotation></passage><passage><infon key="type">abstract</infon><offset>150</offset><text>MicroRNAs (miRNAs) are important regulators of skeletal muscle regeneration, but the underlying mechanisms are still incompletely understood. Here, comparative miRNA sequencing analysis of myogenic progenitor cells (MPs) and non-myogenic fibroblast-adipocyte progenitors (FAPs) during cardiotoxin (CTX)-induced muscle injury uncovered miR-501 as a novel muscle-specific miRNA. miR-501 is an intronic miRNA and its expression levels in MPs correlated with its host gene, chloride channel, voltage-sensitive 5 (Clcn5). Pharmacological inhibition of miR-501 dramatically blunted the induction of embryonic myosin heavy chain (MYH3) and, to a lesser extent, adult myosin isoforms during muscle regeneration, and promoted small-diameter neofibers. An unbiased target identification approach in primary myoblasts validated gigaxonin as a target of miR-501 that mimicked the effect of miR-501 inhibition on MYH3 expression. In the mdx mouse model, which models a pathological disease state, not only was miR-501 induced in regenerating skeletal muscle, but also its serum levels were increased, which correlated with the disease state of the animals. Our results suggest that miR-501 plays a key role in adult muscle regeneration and might serve as a novel serum biomarker for the activation of adult muscle stem cells.</text><annotation id="2"><infon key="identifier">D054715</infon><infon key="type">ChemicalEntity</infon><location offset="435" length="11"/><text>cardiotoxin</text></annotation><annotation id="3"><infon key="identifier">D054715</infon><infon key="type">ChemicalEntity</infon><location offset="448" length="3"/><text>CTX</text></annotation><annotation id="4"><infon key="identifier">D009135</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="461" length="13"/><text>muscle injury</text></annotation><annotation id="5"><infon key="identifier">751560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="485" length="7"/><text>miR-501</text></annotation><annotation id="6"><infon key="identifier">751560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="527" length="7"/><text>miR-501</text></annotation><annotation id="7"><infon key="identifier">12728</infon><infon key="type">GeneOrGeneProduct</infon><location offset="620" length="37"/><text>chloride channel, voltage-sensitive 5</text></annotation><annotation id="8"><infon key="identifier">12728</infon><infon key="type">GeneOrGeneProduct</infon><location offset="659" length="5"/><text>Clcn5</text></annotation><annotation id="9"><infon key="identifier">751560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="697" length="7"/><text>miR-501</text></annotation><annotation id="10"><infon key="identifier">17883</infon><infon key="type">GeneOrGeneProduct</infon><location offset="753" length="18"/><text>myosin heavy chain</text></annotation><annotation id="11"><infon key="identifier">17883</infon><infon key="type">GeneOrGeneProduct</infon><location offset="773" length="4"/><text>MYH3</text></annotation><annotation id="12"><infon key="identifier">17879</infon><infon key="type">GeneOrGeneProduct</infon><location offset="804" length="21"/><text>adult myosin isoforms</text></annotation><annotation id="13"><infon key="identifier">209239</infon><infon key="type">GeneOrGeneProduct</infon><location offset="967" length="9"/><text>gigaxonin</text></annotation><annotation id="14"><infon key="identifier">751560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="992" length="7"/><text>miR-501</text></annotation><annotation id="15"><infon key="identifier">751560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1028" length="7"/><text>miR-501</text></annotation><annotation id="16"><infon key="identifier">17883</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1050" length="4"/><text>MYH3</text></annotation><annotation id="17"><infon key="identifier">10090</infon><infon key="type">OrganismTaxon</infon><location offset="1078" length="5"/><text>mouse</text></annotation><annotation id="18"><infon key="identifier">751560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1147" length="7"/><text>miR-501</text></annotation><annotation id="19"><infon key="identifier">751560</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1319" length="7"/><text>miR-501</text></annotation></passage><relation id="R0"><infon key="entity1">D054715</infon><infon key="entity2">D009135</infon><infon key="type">Positive_Correlation</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">751560</infon><infon key="entity2">12728</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">751560</infon><infon key="entity2">D009135</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">751560</infon><infon key="entity2">17883</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">209239</infon><infon key="entity2">751560</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation></document><document><id>21799811</id><passage><infon key="type">title</infon><offset>0</offset><text>Strong association of 677 C>T substitution in the MTHFR gene with male infertility--a study on an indian population and a meta-analysis.</text><annotation id="0"><infon key="identifier">rs1801133</infon><infon key="type">SequenceVariant</infon><location offset="22" length="7"/><text>677 C>T</text></annotation><annotation id="1"><infon key="identifier">4524</infon><infon key="type">GeneOrGeneProduct</infon><location offset="50" length="5"/><text>MTHFR</text></annotation><annotation id="2"><infon key="identifier">D007248</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="66" length="16"/><text>male infertility</text></annotation></passage><passage><infon key="type">abstract</infon><offset>137</offset><text>BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme of folate and methionine metabolism, making it crucial for DNA synthesis and methylation. The objective of this study was to analyze MTHFR gene 677C>T polymorphism in infertile male individuals from North India, followed by a meta-analysis on our data and published studies. METHODOLOGY/PRINCIPAL FINDINGS: We undertook genotyping on a total of 837 individuals including well characterized infertile (N=522) and confirmed fertile (N=315) individuals. The SNP was typed by direct DNA sequencing. Chi square test was done for statistical analysis. Published studies were searched using appropriate keywords. Source of data collection for meta-analysis included 'Pubmed', 'Ovid' and 'Google Scholar'. Those studies analyzing 677C>T polymorphism in male infertility and presenting all relevant data were included in meta-analysis. The genotype data for infertile subjects and fertile controls was extracted from each study. Chi square test was done to obtain odds ratio (OR) and p-value. Meta-analysis was performed using Comprehensive Meta-analysis software (Version 2). The frequency of mutant (T) allele (p=0.0025) and genotypes (CT+TT) (p=0.0187) was significantly higher in infertile individuals in comparison to fertile controls in our case-control study. The overall summary estimate (OR) for allele and genotype meta-analysis were 1.304 (p=0.000), 1.310 (p=0.000), respectively, establishing significant association of 677C>T polymorphism with male infertility. CONCLUSIONS/SIGNIFICANCE: 677C>T substitution associated strongly with male infertility in Indian population. Allele and genotype meta-analysis also supported its strong correlation with male infertility, thus establishing it as a risk factor.</text><annotation id="3"><infon key="identifier">4524</infon><infon key="type">GeneOrGeneProduct</infon><location offset="149" length="35"/><text>Methylenetetrahydrofolate reductase</text></annotation><annotation id="4"><infon key="identifier">4524</infon><infon key="type">GeneOrGeneProduct</infon><location offset="186" length="5"/><text>MTHFR</text></annotation><annotation id="5"><infon key="identifier">D005492</infon><infon key="type">ChemicalEntity</infon><location offset="219" length="6"/><text>folate</text></annotation><annotation id="6"><infon key="identifier">D008715</infon><infon key="type">ChemicalEntity</infon><location offset="230" length="10"/><text>methionine</text></annotation><annotation id="7"><infon key="identifier">4524</infon><infon key="type">GeneOrGeneProduct</infon><location offset="349" length="5"/><text>MTHFR</text></annotation><annotation id="8"><infon key="identifier">rs1801133</infon><infon key="type">SequenceVariant</infon><location offset="360" length="6"/><text>677C>T</text></annotation><annotation id="9"><infon key="identifier">rs1801133</infon><infon key="type">SequenceVariant</infon><location offset="938" length="6"/><text>677C>T</text></annotation><annotation id="10"><infon key="identifier">D007248</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="961" length="16"/><text>male infertility</text></annotation><annotation id="11"><infon key="identifier">rs1801133</infon><infon key="type">SequenceVariant</infon><location offset="1639" length="6"/><text>677C>T</text></annotation><annotation id="12"><infon key="identifier">D007248</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1664" length="16"/><text>male infertility</text></annotation><annotation id="13"><infon key="identifier">rs1801133</infon><infon key="type">SequenceVariant</infon><location offset="1708" length="6"/><text>677C>T</text></annotation><annotation id="14"><infon key="identifier">D007248</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1753" length="16"/><text>male infertility</text></annotation><annotation id="15"><infon key="identifier">D007248</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1869" length="16"/><text>male infertility</text></annotation></passage><relation id="R0"><infon key="entity1">rs1801133</infon><infon key="entity2">D007248</infon><infon key="type">Positive_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R1"><infon key="entity1">4524</infon><infon key="entity2">D008715</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">4524</infon><infon key="entity2">D005492</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">4524</infon><infon key="entity2">D007248</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>15951966</id><passage><infon key="type">title</infon><offset>0</offset><text>Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH.</text><annotation id="0"><infon key="identifier">4436</infon><infon key="type">GeneOrGeneProduct</infon><location offset="46" length="4"/><text>MSH2</text></annotation><annotation id="1"><infon key="identifier">4292</infon><infon key="type">GeneOrGeneProduct</infon><location offset="55" length="4"/><text>MLH1</text></annotation></passage><passage><infon key="type">abstract</infon><offset>69</offset><text>BACKGROUND: Exonic deletions in MSH2 and MLH1 are significant contributors to the mutation spectrum in HNPCC, and heterozygous changes in exon copy number are not detected by conventional mutation screening methods. AIMS: We aimed to develop methods for screening copy number changes in all the exons of the MLH1 and MSH2 genes using a single multiplex amplifiable probe hybridisation (MAPH) assay. METHODS: We developed a probe set consisting of probes from the 19 exons of MLH1 and 16 exons of MSH2, and 3 control probes, and applied it to screening for deletions and duplications using fluorescent detection of amplified fragments. RESULTS: We tested 73 DNA samples from controls and 50 from HNPCC patients in whom no point mutations had been found, and detected 10 copy number changes among the patient samples. A deletion of about 1.4 kb including exon 3 of MSH2 was confirmed by amplification of a junction fragment, and was shown to be the result of an unequal recombination between intronic Alu elements. CONCLUSIONS: MAPH can detect exonic copy number changes in MLH1 and MSH2 in DNA from HNPCC patients. Since finding an exonic deletion or duplication makes full sequence analysis unnecessary, it may be most cost-effective to pre-screen samples by MAPH or MLPA before screening for point mutations.</text><annotation id="2"><infon key="identifier">4436</infon><infon key="type">GeneOrGeneProduct</infon><location offset="101" length="4"/><text>MSH2</text></annotation><annotation id="3"><infon key="identifier">4292</infon><infon key="type">GeneOrGeneProduct</infon><location offset="110" length="4"/><text>MLH1</text></annotation><annotation id="4"><infon key="identifier">D003123</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="172" length="5"/><text>HNPCC</text></annotation><annotation id="5"><infon key="identifier">4292</infon><infon key="type">GeneOrGeneProduct</infon><location offset="377" length="4"/><text>MLH1</text></annotation><annotation id="6"><infon key="identifier">4436</infon><infon key="type">GeneOrGeneProduct</infon><location offset="386" length="4"/><text>MSH2</text></annotation><annotation id="7"><infon key="identifier">4292</infon><infon key="type">GeneOrGeneProduct</infon><location offset="544" length="4"/><text>MLH1</text></annotation><annotation id="8"><infon key="identifier">4436</infon><infon key="type">GeneOrGeneProduct</infon><location offset="565" length="4"/><text>MSH2</text></annotation><annotation id="9"><infon key="identifier">D003123</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="764" length="5"/><text>HNPCC</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="770" length="8"/><text>patients</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="868" length="7"/><text>patient</text></annotation><annotation id="12"><infon key="identifier">4436</infon><infon key="type">GeneOrGeneProduct</infon><location offset="932" length="4"/><text>MSH2</text></annotation><annotation id="13"><infon key="identifier">4292</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1141" length="4"/><text>MLH1</text></annotation><annotation id="14"><infon key="identifier">4436</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1150" length="4"/><text>MSH2</text></annotation><annotation id="15"><infon key="identifier">D003123</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1167" length="5"/><text>HNPCC</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1173" length="8"/><text>patients</text></annotation></passage><relation id="R0"><infon key="entity1">4292</infon><infon key="entity2">D003123</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">4436</infon><infon key="entity2">D003123</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation></document><document><id>17968299</id><passage><infon key="type">title</infon><offset>0</offset><text>Analysis of -1082 IL-10 gene polymorphism in Iranian patients with generalized aggressive periodontitis.</text><annotation id="0"><infon key="identifier">3586</infon><infon key="type">GeneOrGeneProduct</infon><location offset="18" length="5"/><text>IL-10</text></annotation><annotation id="1"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="53" length="8"/><text>patients</text></annotation><annotation id="2"><infon key="identifier">D010520</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="79" length="24"/><text>aggressive periodontitis</text></annotation></passage><passage><infon key="type">abstract</infon><offset>105</offset><text>BACKGROUND: Periodontitis is a multifactorial disease and its severe forms, such as aggressive periodontitis, are suggested to have a genetic basis. Among the genetic factors, polymorphisms in cytokine genes have recently been described in susceptibility to periodontitis. IL-10 is a multi-functional cytokine thought to play a role in the pathogenesis of periodontitis. A substitution G/A polymorphism in the promoter region of the IL-10 gene at position -1082 has been associated with different amounts of IL-10 production. The aim of the present study was to investigate the possible links between -1082(G/A) polymorphism of the IL-10 gene and the generalized form of aggressive periodontitis. MATERIAL/METHODS: This study included 52 Iranian Khorasanian (north-east province of Iran) subjects suffering from generalized aggressive periodontitis referred to the Periodontology Department of Mashhad Dental School. They were compared to 61 age and sex-matched healthy controls of the same race. DNA was isolated from peripheral blood cells and genotyping was performed by means of the amplification refractory mutation system polymerase chain reaction (ARMS-PCR) method. Data were analyzed using the chi-squared test. RESULTS: There was no marked difference in genotype frequencies between the controls and generalized aggressive periodontitis patients (p=0.585). Moreover, no association between patients and normal subjects was found in their allele frequency (p=0.329). CONCLUSIONS: We conclude that the polymorphic nucleotide A at position -1082 of the IL-10 gene is not associated with generalized aggressive periodontitis in the Iranian population.</text><annotation id="3"><infon key="identifier">D010518</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="117" length="13"/><text>Periodontitis</text></annotation><annotation id="4"><infon key="identifier">D010520</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="189" length="24"/><text>aggressive periodontitis</text></annotation><annotation id="5"><infon key="identifier">D010518</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="363" length="13"/><text>periodontitis</text></annotation><annotation id="6"><infon key="identifier">3586</infon><infon key="type">GeneOrGeneProduct</infon><location offset="378" length="5"/><text>IL-10</text></annotation><annotation id="7"><infon key="identifier">D010518</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="461" length="13"/><text>periodontitis</text></annotation><annotation id="8"><infon key="identifier">c|SUB|G||A</infon><infon key="type">SequenceVariant</infon><location offset="491" length="3"/><text>G/A</text></annotation><annotation id="9"><infon key="identifier">3586</infon><infon key="type">GeneOrGeneProduct</infon><location offset="538" length="5"/><text>IL-10</text></annotation><annotation id="10"><infon key="identifier">3586</infon><infon key="type">GeneOrGeneProduct</infon><location offset="613" length="5"/><text>IL-10</text></annotation><annotation id="11"><infon key="identifier">c|SUB|G|-1082|A</infon><infon key="type">SequenceVariant</infon><location offset="706" length="10"/><text>-1082(G/A)</text></annotation><annotation id="12"><infon key="identifier">3586</infon><infon key="type">GeneOrGeneProduct</infon><location offset="737" length="5"/><text>IL-10</text></annotation><annotation id="13"><infon key="identifier">D010520</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="776" length="24"/><text>aggressive periodontitis</text></annotation><annotation id="14"><infon key="identifier">D010520</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="929" length="24"/><text>aggressive periodontitis</text></annotation><annotation id="15"><infon key="identifier">D010520</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1426" length="24"/><text>aggressive periodontitis</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1451" length="8"/><text>patients</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="1504" length="8"/><text>patients</text></annotation><annotation id="18"><infon key="identifier">c|Allele|A|-1082</infon><infon key="type">SequenceVariant</infon><location offset="1637" length="19"/><text>A at position -1082</text></annotation><annotation id="19"><infon key="identifier">3586</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1664" length="5"/><text>IL-10</text></annotation><annotation id="20"><infon key="identifier">D010520</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1710" length="24"/><text>aggressive periodontitis</text></annotation></passage><relation id="R0"><infon key="entity1">3586</infon><infon key="entity2">D010518</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation></document><document><id>20126413</id><passage><infon key="type">title</infon><offset>0</offset><text>U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line.</text><annotation id="0"><infon key="identifier">CVCL_0022</infon><infon key="type">CellLine</infon><location offset="0" length="5"/><text>U87MG</text></annotation><annotation id="1"><infon key="identifier">9606</infon><infon key="type">OrganismTaxon</infon><location offset="66" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">D009369</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="72" length="6"/><text>cancer</text></annotation></passage><passage><infon key="type">abstract</infon><offset>90</offset><text>U87MG is a commonly studied grade IV glioma cell line that has been analyzed in at least 1,700 publications over four decades. In order to comprehensively characterize the genome of this cell line and to serve as a model of broad cancer genome sequencing, we have generated greater than 30x genomic sequence coverage using a novel 50-base mate paired strategy with a 1.4kb mean insert library. A total of 1,014,984,286 mate-end and 120,691,623 single-end two-base encoded reads were generated from five slides. All data were aligned using a custom designed tool called BFAST, allowing optimal color space read alignment and accurate identification of DNA variants. The aligned sequence reads and mate-pair information identified 35 interchromosomal translocation events, 1,315 structural variations (>100 bp), 191,743 small (&lt;21 bp) insertions and deletions (indels), and 2,384,470 single nucleotide variations (SNVs). Among these observations, the known homozygous mutation in PTEN was robustly identified, and genes involved in cell adhesion were overrepresented in the mutated gene list. Data were compared to 219,187 heterozygous single nucleotide polymorphisms assayed by Illumina 1M Duo genotyping array to assess accuracy: 93.83% of all SNPs were reliably detected at filtering thresholds that yield greater than 99.99% sequence accuracy. Protein coding sequences were disrupted predominantly in this cancer cell line due to small indels, large deletions, and translocations. In total, 512 genes were homozygously mutated, including 154 by SNVs, 178 by small indels, 145 by large microdeletions, and 35 by interchromosomal translocations to reveal a highly mutated cell line genome. Of the small homozygously mutated variants, 8 SNVs and 99 indels were novel events not present in dbSNP. These data demonstrate that routine generation of broad cancer genome sequence is possible outside of genome centers. The sequence analysis of U87MG provides an unparalleled level of mutational resolution compared to any cell line to date.</text><annotation id="3"><infon key="identifier">CVCL_0022</infon><infon key="type">CellLine</infon><location offset="90" length="5"/><text>U87MG</text></annotation><annotation id="4"><infon key="identifier">D005909</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="118" length="15"/><text>grade IV glioma</text></annotation><annotation id="5"><infon key="identifier">D009369</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="320" length="6"/><text>cancer</text></annotation><annotation id="6"><infon key="identifier">5728</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1068" length="4"/><text>PTEN</text></annotation><annotation id="7"><infon key="identifier">D009369</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1498" length="6"/><text>cancer</text></annotation><annotation id="8"><infon key="identifier">D009369</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1941" length="6"/><text>cancer</text></annotation><annotation id="9"><infon key="identifier">CVCL_0022</infon><infon key="type">CellLine</infon><location offset="2028" length="5"/><text>U87MG</text></annotation></passage><relation id="R0"><infon key="entity1">5728</infon><infon key="entity2">D009369</infon><infon key="type">Association</infon><infon key="novel">Novel</infon></relation></document><document><id>27866394</id><passage><infon key="type">title</infon><offset>0</offset><text>Repeated otilonium bromide administration prevents neurotransmitter changes in colon of rats underwent to wrap restraint stress.</text><annotation id="0"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="9" length="17"/><text>otilonium bromide</text></annotation><annotation id="1"><infon key="identifier">D018377</infon><infon key="type">ChemicalEntity</infon><location offset="51" length="16"/><text>neurotransmitter</text></annotation><annotation id="2"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="88" length="4"/><text>rats</text></annotation></passage><passage><infon key="type">abstract</infon><offset>129</offset><text>Otilonium bromide (OB) is a spasmolytic drug successfully used for the treatment of irritable bowel syndrome (IBS). Its efficacy has been attributed to the block of L- and T-type Ca(2+) channels and muscarinic and tachykinin receptors in the smooth muscle. Furthermore, in healthy rats, repeated OB administration modified neurotransmitter expression and function suggesting other mechanisms of action. On this basis, we investigated whether repeated OB treatment prevented the functional and neurochemical changes observed in the colon of rats underwent to wrap restrain stress (WRS) a psychosocial stressor considered suitable to reproduce the main IBS signs and symptoms. In control, WRS and OB/WRS rats functional parameters were measured in vivo and morphological investigations were done ex vivo in the colon. The results showed that OB counteracts most of the neurotransmitters changes caused by WRS. In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100b-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR. On the contrary, OB does not affect the increase in CRF2r-IR neurons observed in WRS rats and does not interfere with the mild mucosal inflammation due to WRS. Finally, OB per se increases the Mr2 expression in the muscle wall and decreases the number of the myenteric ChAT-IR neurons. Functional findings show a significantly reduction in the number of spontaneous abdominal contraction in OB treated rats. The ability of OB to block L-type Ca(2+) channels, also expressed by enteric neurons, might represent a possible mechanism through which OB exerts its actions.</text><annotation id="3"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="129" length="17"/><text>Otilonium bromide</text></annotation><annotation id="4"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="148" length="2"/><text>OB</text></annotation><annotation id="5"><infon key="identifier">D043183</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="213" length="24"/><text>irritable bowel syndrome</text></annotation><annotation id="6"><infon key="identifier">D043183</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="239" length="3"/><text>IBS</text></annotation><annotation id="7"><infon key="identifier">24239,83810</infon><infon key="type">GeneOrGeneProduct</infon><location offset="294" length="29"/><text>L- and T-type Ca(2+) channels</text></annotation><annotation id="8"><infon key="identifier">1128,6869</infon><infon key="type">GeneOrGeneProduct</infon><location offset="328" length="35"/><text>muscarinic and tachykinin receptors</text></annotation><annotation id="9"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="410" length="4"/><text>rats</text></annotation><annotation id="10"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="425" length="2"/><text>OB</text></annotation><annotation id="11"><infon key="identifier">D018377</infon><infon key="type">ChemicalEntity</infon><location offset="452" length="16"/><text>neurotransmitter</text></annotation><annotation id="12"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="580" length="2"/><text>OB</text></annotation><annotation id="13"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="669" length="4"/><text>rats</text></annotation><annotation id="14"><infon key="identifier">D043183</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="780" length="3"/><text>IBS</text></annotation><annotation id="15"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="824" length="2"/><text>OB</text></annotation><annotation id="16"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="831" length="4"/><text>rats</text></annotation><annotation id="17"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="969" length="2"/><text>OB</text></annotation><annotation id="18"><infon key="identifier">D018377</infon><infon key="type">ChemicalEntity</infon><location offset="996" length="17"/><text>neurotransmitters</text></annotation><annotation id="19"><infon key="identifier">24806</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1086" length="2"/><text>SP</text></annotation><annotation id="20"><infon key="identifier">24807</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1091" length="4"/><text>NK1r</text></annotation><annotation id="21"><infon key="identifier">24598</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1098" length="4"/><text>nNOS</text></annotation><annotation id="22"><infon key="identifier">117064</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1105" length="3"/><text>VIP</text></annotation><annotation id="23"><infon key="identifier">25742</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1115" length="5"/><text>S100b</text></annotation><annotation id="24"><infon key="identifier">24241</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1163" length="4"/><text>CGRP</text></annotation><annotation id="25"><infon key="identifier">58959</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1174" length="5"/><text>CRF1r</text></annotation><annotation id="26"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="1201" length="2"/><text>OB</text></annotation><annotation id="27"><infon key="identifier">64680</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1236" length="5"/><text>CRF2r</text></annotation><annotation id="28"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="1269" length="4"/><text>rats</text></annotation><annotation id="29"><infon key="identifier">D052016</infon><infon key="type">DiseaseOrPhenotypicFeature</infon><location offset="1311" length="20"/><text>mucosal inflammation</text></annotation><annotation id="30"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="1353" length="2"/><text>OB</text></annotation><annotation id="31"><infon key="identifier">81645</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1377" length="3"/><text>Mr2</text></annotation><annotation id="32"><infon key="identifier">290567</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1453" length="4"/><text>ChAT</text></annotation><annotation id="33"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="1575" length="2"/><text>OB</text></annotation><annotation id="34"><infon key="identifier">10116</infon><infon key="type">OrganismTaxon</infon><location offset="1586" length="4"/><text>rats</text></annotation><annotation id="35"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="1607" length="2"/><text>OB</text></annotation><annotation id="36"><infon key="identifier">24239</infon><infon key="type">GeneOrGeneProduct</infon><location offset="1619" length="22"/><text>L-type Ca(2+) channels</text></annotation><annotation id="37"><infon key="identifier">C013934</infon><infon key="type">ChemicalEntity</infon><location offset="1729" length="2"/><text>OB</text></annotation></passage><relation id="R0"><infon key="entity1">83810</infon><infon key="entity2">D043183</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R1"><infon key="entity1">83810</infon><infon key="entity2">C013934</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R2"><infon key="entity1">24239</infon><infon key="entity2">D043183</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R3"><infon key="entity1">24239</infon><infon key="entity2">C013934</infon><infon key="type">Negative_Correlation</infon><infon key="novel">Novel</infon></relation><relation id="R4"><infon key="entity1">6869</infon><infon key="entity2">D043183</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R5"><infon key="entity1">6869</infon><infon key="entity2">C013934</infon><infon key="type">Negative_Correlation</infon><infon key="novel">No</infon></relation><relation id="R6"><infon key="entity1">1128</infon><infon key="entity2">D043183</infon><infon key="type">Association</infon><infon key="novel">No</infon></relation><relation id="R7"><infon key="entit